RADIATION CONTROL - LICENSING OF RADIOACTIVE MATERIAL
ColoradoRegulations
Ask Donna
How this section applies to your facts.
Code of Colorado Regulations › 1000 Department of Public Health and Environment › 1007 Hazardous Materials and Waste Management Division › 6 CCR 1007-1 Part 03
Text
_________________________________________________________________________
Adopted by the Board of Health on October 18, 2023; effective December 15, 2023.
LICENSING OF RADIOACTIVE MATERIAL
3.1
Purpose and Scope
3.1.1
Authority.
3.1.1.1 Rules and regulations set forth herein are adopted pursuant to the provisions of sections
25-1-108, 25-1.5-101(1)(k) and (1)(l), and 25-11-104, CRS.
3.1.2
Basis and Purpose.
3.1.2.1 A statement of basis and purpose of these regulations is incorporated as part of these
regulations; a copy may be obtained from the Department.
3.1.3
Scope.
3.1.3.1 This part, and Parts 5, 7, 14, 16, 17, 18, and 19 of these regulations, provide for the
licensing of radioactive material.
3.1.3.2 No person shall receive, possess, own, acquire, process, use, store, transfer, or dispose
radioactive material except as authorized pursuant to this part or Parts 5, 7, 14, 17, 18, or
19 of these regulations, or as otherwise provided in these parts.
3.1.4
Applicability.
3.1.4.1 In addition to the requirements of this part, all licensees are subject to the requirements
of Parts 1, 4, 10, 12 and 17.
3.1.4.2 Furthermore:
(1)
Licensees engaged in industrial radiographic operations are subject to the
requirements of Part 5.
(2)
Licensees using radionuclides in the healing arts are subject to the requirements
of Part 7.
(3)
Licensees engaged in land disposal of radioactive material are subject to the
requirements of either Part 14 or Part 18, as appropriate.
(4)
Licensees engaged in source material milling are subject to the requirements of
Part 18.
(5)
Licensees engaged in wireline and subsurface tracer studies are subject to the
requirements of Part 16.
(6)
Panoramic or underwater irradiator licensees are subject to the requirements of
Part 19.
Published material incorporated by reference.
3.1.4.3 Throughout this Part 3, federal regulations, state regulations, and standards or guidelines
of outside organizations have been adopted and incorporated by reference. Unless a
prior version of the incorporated material is otherwise specifically indicated, the materials
incorporated by reference cited herein include only those versions that were in effect as
of the most recent effective date of this Part 3 (December 2023), and not later
amendments or editions of the incorporated material.
3.1.4.4 Materials incorporated by reference are available for public inspection, and copies
(including certified copies) can be obtained at reasonable cost, during normal business
hours from the Colorado Department of Public Health and Environment, Hazardous
Materials and Waste Management Division, 4300 Cherry Creek Drive South, Denver,
Colorado 80246. Additionally, https://cdphe.colorado.gov/hm/radregs identifies where the
incorporated federal and state regulations are available to the public on the internet at no
cost. A copy of the materials incorporated in this Part is available for public inspection at
the state publications depository and distribution center.
3.1.4.5 Availability from Source Agencies or Organizations.
(1)
All federal agency regulations incorporated by reference herein are available at
no cost in the online edition of the Code of Federal Regulations (CFR) hosted by
the U.S. Government Printing Office, online at
https://www.govinfo.gov/app/collection/cfr/.
(2)
All state regulations incorporated by reference herein are available at no cost in
the online edition of the Code of Colorado Regulations (CCR) hosted by the
Colorado Secretary of State’s Office, online at
https://www.sos.state.co.us/CCR/Welcome.do.
3.1.5
Definitions
3.1.5.1 Definitions of general applicability to these regulations are in Part 1, Section 1.2.
3.1.5.2 As used in Part 3, each term below has the definition set forth.
“Consortium” means an association of medical use licensees and a Positron Emission
Tomography (PET) radionuclide production facility in the same geographical area that
jointly own or share in the operation and maintenance cost of the PET radionuclide
production facility that produces PET radionuclides for use in producing radioactive drugs
within the consortium for noncommercial distributions among its associated members for
medical use. The PET radionuclide production facility within the consortium must be
located at an educational institution or a Federal facility or a medical facility.
3.1.6
The Department may engage the services of qualified persons in order to assist the Department
in meeting the requirements of these regulations, including, but not limited to, evaluating
information that may be required under 3.8.8.
3.1.6.1 Fees for these services may be charged by the Department as a part of fees charged for
radiation control services under Part 12.
EXEMPTIONS FROM THE REGULATORY REQUIREMENTS
3.2
Exemption Of Source Material
3.2.1
Any person is exempt from this part to the extent that such person receives, possesses, uses,
owns, or transfers source material in any chemical mixture, compound, solution, or alloy in which
the source material is by weight less than 1/20th of 1 percent (0.05 percent) of the mixture,
compound, solution, or alloy.
3.2.2
Any person is exempt from this part to the extent that such person receives, possesses, uses, or
transfers unrefined and unprocessed ore containing source material; provided that, except as
authorized in a specific license, such person shall not refine or process such ore.
3.2.3
Any person is exempt from this part to the extent that such person receives, possesses, uses, or
transfers an item containing uranium or thorium listed in Schedule 3C, Sections 3C.1 through
3C.10.
3.2.3.1 The exemptions listed in Schedule 3C do not authorize the manufacture of any of the
products described.
3.3
Exemption Of Radioactive Material Other Than Source Material.
3.3.1
Exempt Concentrations.
3.3.1.1 Except as provided in 3.3.1.2, any person is exempt from this part to the extent that such
person receives, possesses, uses, transfers, or acquires products containing radioactive
material introduced in concentrations not in excess of those listed in Schedule 3A.
(1)
A manufacturer, processor, or producer that transfers a product or material is
exempt so long as concentrations less than those listed in schedule 3A were
introduced under an NRC license so authorizing.
(2)
Transfer of radioactive material contained in any food, beverage, cosmetic, drug,
or other commodity or product designed for ingestion or inhalation by, or
application to, a human being, is not exempt under 3.3.1.1(1).
3.3.1.2 No person may introduce radioactive material into a product or material knowing or
having reason to believe that it will be transferred to persons exempt under 3.3.1.1 or
equivalent regulations of NRC or any Agreement State, except in accordance with a
specific license issued consistent with 3.12.1 or the general license provided in 3.24.
3.3.2
Exempt Quantities.
3.3.2.1 Except as provided in 3.3.2.3 and 3.3.2.4, any person is exempt from these regulations to
the extent that such person receives, possesses, uses, transfers, owns, or acquires
radioactive material in individual quantities each of which does not exceed the applicable
quantity set forth in Schedule 3B.
3.3.2.2 Any person who possesses radioactive material received or acquired under the general
license formerly provided under 10 CFR Part 31.4 before September 25, 1971 is exempt
from the requirements for a license set forth in this part to the extent that such person
possesses, uses, transfers or owns such radioactive material.
3.3.2.3 Section 3.3.2 does not authorize the production, packaging or repackaging of radioactive
material for purposes of commercial distribution, or the incorporation of radioactive
material into products intended for commercial distribution.
3.3.2.4 No person may, for purposes of commercial distribution, transfer radioactive material in
the individual quantities set forth in Schedule 3B, knowing or having reason to believe
that such quantities of radioactive material will be transferred to persons exempt under
3.3.2 or equivalent regulations of NRC or any Agreement State except in accordance with
a specific license issued by NRC pursuant to Section 32.18 of 10 CFR Part 32, which
license states that the radioactive material may be transferred by the licensee to persons
exempt under 3.3.2 or the equivalent regulations of NRC or an Agreement State.1
1 Authority to transfer possession or control by the manufacturer, processor, or producer of any equipment, device, commodity, or
other product containing byproduct material whose subsequent possession, use, transfer, and disposal by all other persons are
exempted from regulatory requirements may be obtained only from the U.S. Nuclear Regulatory Commission, Washington, D.C.
20555.
3.3.2.5 No person may, for purposes of producing an increased radiation level, combine
quantities of radioactive material covered by this exemption so that the aggregate
quantity exceeds the limits set forth in Schedule 3B, except for a device placed in use
before May 3, 1999, or as otherwise permitted by these regulations.
3.3.3
Exempt Items.
3.3.3.1 Any person is exempt from this part to the extent that such person receives, possesses,
uses, or transfers an item containing radioactive material which is listed in Schedule 3C,
Sections 3C.11 through 3C.14.
LICENSES
3.4
Types of Licenses.
Licenses for radioactive materials are of two types: general and specific.
3.4.1
A general license is provided by regulation and grants authority to a person for certain activities
involving radioactive material.
3.4.1.1 A general license is effective without the filing of an application with the Department or
the issuance of a licensing document to a particular person.
3.4.1.2 However, registration or filing of a certificate with the Department may be required by the
particular general license.
3.4.1.3 The general licensee is subject to all other applicable portions of these regulations and
any limitations of the general license.
3.4.2
A specific license requires the submission of an application to the Department and the issuance
of a licensing document by the Department.
3.4.2.1 The licensee is subject to all applicable portions of these regulations as well as any
limitations specified in the licensing document.
GENERAL LICENSES
3.5
General Licenses – Small Quantities Of Source Material.
3.5.1
A general license is hereby issued authorizing commercial and industrial firms; research,
educational and medical institutions; and Federal, State and local government agencies to
receive, possess, use and transfer uranium and thorium, in their natural isotopic concentrations
and in the form of depleted uranium, for research, development, educational, commercial, or
operational purposes in the following forms and quantities:
3.5.1.1 No more than 1.5 kg (3.3 lb) of uranium and thorium in dispersible forms (e.g., gaseous,
liquid, powder, etc.) at any one time. Any material processed by the general licensee that
alters the chemical or physical form of the material containing source material must be
accounted for as a dispersible form. A person authorized to possess, use, and transfer
source material under 3.5.1.1 may not receive more than a total of 7 kg (15.4 lb) of
uranium and thorium in any one calendar year. Persons possessing source material in
excess of these limits as of August 27, 2016, may continue to possess up to 7 kg (15.4
lb) of uranium and thorium at any one time for one year beyond this date, or until the
Department takes final action on a pending application submitted on or before August 27,
2017, for a specific license for such material; and receive up to 70 kg (154 lb) of uranium
or thorium in any one calendar year until December 31, 2017, or until the Department
takes final action on a pending application submitted on or before August 27, 2017, for a
specific license for such material; and
3.5.1.2 No more than a total of 7 kg (15.4 lb) of uranium and thorium at any one time. A person
authorized to possess, use, and transfer source material under 3.5.1.2 may not receive
more than a total of 70 kg (154 lb) of uranium and thorium in any one calendar year. A
person may not alter the chemical or physical form of the source material possessed
under 3.5.1.2 unless it is accounted for under the limits of 3.5.1.1; or
3.5.1.3 No more than 7 kg (15.4 lb) of uranium, removed during the treatment of drinking water,
at any one time. A person may not remove more than 70 kg (154 lb) of uranium from
drinking water during a calendar year under 3.5.1.3; or
3.5.1.4 No more than 7 kg (15.4 lb) of uranium and thorium at laboratories for the purpose of
determining the concentration of uranium and thorium contained within the material being
analyzed at any one time. A person authorized to possess, use, and transfer source
material under 3.5.1.4 may not receive more than a total of 70 kg (154 lb) of source
material in any one calendar year.
3.5.2
Any person who receives, possesses, uses or transfers source material in accordance with the
general license in 3.5.1:
3.5.2.1 Is prohibited from administering source material, or the radiation therefrom, either
externally or internally, to human beings except as may be authorized by the Department,
NRC, or an Agreement State in a specific license.
3.5.2.2 Shall not abandon such source material. Source material may be disposed of as follows:
(1)
A cumulative total of 0.5 kg (1.1 lb) of source material in a solid, non-dispersible
form may be transferred each calendar year, by a person authorized to receive,
possess, use, and transfer source material under this general license to persons
receiving the material for permanent disposal. The recipient of source material
transferred under the provisions of this paragraph is exempt from the
requirements to obtain a license under this part to the extent the source material
is permanently disposed. This provision does not apply to any person who is in
possession of source material under a specific license issued under this chapter;
or
(2)
In accordance with 4.33.
3.5.2.3 Is subject to the provisions in 3.1, 3.14.2, 3.15.1 through 3.15.3, 3.15.2.1, 3.15.4.2,
through 3.15.4.4, 3.22, 3.23, 4.40, 4.50, 4.52, and 10.5.1.
3.5.2.4 Shall respond to written requests from the Department to provide information relating to
the general licensee within 30 calendar days of the date of the request, or other time
specified in the request. If the person cannot provide the requested information within the
allotted time, the person shall, within that same time period, request a longer period to
supply the information by providing the Department a written justification for the request;
3.5.2.5 Shall not export such source material except in accordance with a license issued by NRC
pursuant to 10 CFR Part 110.
3.5.3
Any person who receives, possesses, uses, or transfers source material in accordance with 3.5.1
shall conduct activities so as to minimize contamination of the facility and the environment. When
activities involving such source material are permanently ceased at any site, if evidence of
significant contamination is identified, the general licensee shall notify the Department about such
contamination and may consult with the Department as to the appropriateness of sampling and
restoration activities to ensure that any contamination or residual source material remaining at the
site where source material was used under this general license is not likely to result in exposures
that exceed the limits in 4.61.2.
3.5.4
Any person who receives, possesses, uses, or transfers source material in accordance with the
general license granted in 3.5.1 is exempt from the provisions of Parts 4 and 10 to the extent that
such receipt, possession, use, and transfer are within the terms of such general license, except
that such person shall comply with the provisions of 4.61.2 and 4.33 to the extent necessary to
meet the provisions of 3.5.2.2 and 3.5.3. However, this exemption does not apply to any person
who also holds a specific license issued under Part 3.
3.5.5
No person may initially transfer or distribute source material to persons generally licensed under
3.5.1.1 or 3.5.1.2, or equivalent regulations of an Agreement State or NRC, unless authorized by
a specific license issued in accordance with 3.22.6 or equivalent provisions of an Agreement
State or NRC. This prohibition does not apply to analytical laboratories returning processed
samples to the client who initially provided the sample. Initial distribution of source material to
persons generally licensed under 3.5.1 before August 27, 2016, without specific authorization
may continue for 1 year beyond this date. Distribution may also be continued until the Department
takes final action on a pending application for license or license amendment to specifically
authorize distribution submitted on or before August 27, 2017.
3.5.6
A general license is hereby issued authorizing the receipt of title to source material without regard
to quantity.
3.5.6.1 This general license does not authorize any person to receive, possess, use, or transfer
source material.
3.5.7
A general license is hereby issued authorizing the possession of source material involved in
mining operations provided such operations meet the regulatory requirements of the Division of
Reclamation, Mining and Safety, Colorado Department of Natural Resources, or any successor
thereto, and, except as authorized in a specific license, such mining operations shall not refine or
process such ore.
3.5.8
Depleted Uranium in Industrial Products and Devices.
3.5.8.1 A general license is hereby issued to receive, acquire, possess, use, or transfer, in
accordance with the provisions of 3.5.8.2, 3.5.8.3, and 3.5.8.4, depleted uranium
contained in industrial products or devices for the purpose of providing a concentrated
mass in a small volume of the product or device.
3.5.8.2 The general license in 3.5.8.1 applies only to industrial products or devices which have
been manufactured either in accordance with a specific license issued to the
manufacturer of the products or devices pursuant to 3.12.13 or in accordance with a
specific license issued to the manufacturer by the NRC or an Agreement State which
authorizes manufacture of the products or devices for distribution to persons generally
licensed by the NRC or an Agreement State.
(1)
Persons who receive, acquire, possess, or use depleted uranium pursuant to the
general license established by 3.5.8.1 shall file Department Form R-52,
“Registration Certificate - Use of Depleted Uranium Under General License”, with
the Department.
(a)
The form shall be submitted within 30 days after the first receipt or
acquisition of such depleted uranium.
(b)
The general licensee shall furnish on Department Form R-52 the
following information and such other information as may be required by
that form:
(i)
Name and address of the general licensee;
(ii)
A statement that the general licensee has developed and will
maintain procedures designed to establish physical control over
the depleted uranium described in 3.5.8.1 and designed to
prevent transfer of such depleted uranium in any form, including
metal scrap, to persons not authorized to receive the depleted
uranium; and
(iii)
Name and title, address, and telephone number of the individual
duly authorized to act for and on behalf of the general licensee in
supervising the procedures identified in 3.5.8.2(1)(b)(ii).
(2)
The general licensee possessing or using depleted uranium under the general
license established by 3.5.8.1 shall report in writing to the Department any
changes in information previously furnished using Department Form R-52,
“Registration Certificate - Use of Depleted Uranium Under General License”. The
report shall be submitted within 30 days after the effective date of such change.
3.5.8.3 A person who receives, acquires, possesses, or uses depleted uranium pursuant to the
general license established by 3.5.8.1:
(1)
Shall not introduce such depleted uranium, in any form, into a chemical, physical,
or metallurgical treatment or process, except a treatment or process for repair or
restoration of any plating or other covering of the depleted uranium;
(2)
Shall not abandon such depleted uranium;
(3)
Shall transfer or dispose of such depleted uranium only by transfer in accordance
with the provisions of 3.22.
(a)
In the case where the transferee receives the depleted uranium pursuant
to the general license established by 3.5.8.1, the transferor shall furnish
the transferee a copy of this regulation and a copy of Department Form
R-52.
(b)
In the case where the transferee receives the depleted uranium pursuant
to a general license contained in NRC's or Agreement State's regulation
equivalent to 3.5.8.1, the transferor shall furnish the transferee a copy of
this regulation and a copy of Department Form R-52 accompanied by a
note explaining that use of the product or device is regulated by NRC or
Agreement State under requirements substantially the same as those in
this regulation;
(4)
Within 30 days of any transfer, shall report in writing to the Department the name
and address of the person receiving the depleted uranium pursuant to such
transfer, and
(5)
Shall not export such depleted uranium except in accordance with a license
issued by NRC pursuant to 10 CFR Part 110.
3.5.8.4 Any person receiving, acquiring, possessing, using, or transferring depleted uranium
pursuant to the general license established by 3.5.8.1 is exempt from the requirements of
Parts 4 and 10 with respect to the depleted uranium covered by that general license.
3.6
General Licenses2 - Radioactive Material Other Than Source Material.
2 Different general licenses are issued in this section, each of which has its own specific conditions and requirements.
3.6.1
Reserved.
3 Reserved
3.6.2
Reserved.
3.6.3
Reserved.
3.6.4
Certain Measuring, Gauging or Controlling Devices.
3.6.4.1 A general license is hereby issued to commercial and industrial firms and to research,
educational and medical institutions, individuals in the conduct of their business, and
State or local government agencies to receive, acquire, possess, use or transfer, in
accordance with the provisions of 3.6.4.2, 3.6.4.3, and 3.6.4.4, radioactive material,
excluding special nuclear material, contained in devices designed and manufactured for
the purpose of detecting, measuring, gauging or controlling thickness, density, level,
interface location, radiation, leakage, or qualitative or quantitative chemical composition,
or for producing light or an ionized atmosphere.
3.6.4.2 The general license in 3.6.4.1 applies only to radioactive material contained in devices
which have been:
(1)
Manufactured or initially transferred and labeled for distribution to persons
generally licensed in accordance with the specifications contained in a specific
license issued by:
(a)
The Department pursuant to 3.12.4 or
(b)
The NRC or an Agreement State4
4 Regulations under the Federal Food, Drug, and Cosmetic Act authorizing the use of radioactive control devices in food production
require certain additional labeling thereon which is found in 21 CFR 179.21.
(2)
Received from one of the specific licensees described in 3.6.4.2(1) or through a
transfer made under 3.6.4.3(8).
3.6.4.3 Any person who owns, receives, acquires, possesses, uses, owns, or transfers
radioactive material in a device pursuant to the general license in 3.6.4.1:
(1)
Shall assure that all labels affixed to the device at the time of receipt, and bearing
a statement that removal of the label is prohibited, are maintained thereon and
shall comply with all instructions and precautions provided by such labels;
(2)
Shall assure that the device is tested for leakage of radioactive material and
proper operation of the “on-off” mechanism and indicator, if any, at no longer
than 6-month intervals or at such other intervals as are specified in the label,
however;
(a)
Devices containing only krypton need not be tested for leakage of
radioactive material; and
(b)
Devices containing only tritium or not more than 3.7 MBq (100 µCi) of
other beta- and/or gamma-emitting material or 0.37 MBq (10 µCi) of
alpha-emitting material and devices held in storage in the original
shipping container prior to initial installation need not be tested for any
purpose.
(3)
Shall assure that the tests required by 3.6.4.3(2) of this section and other testing,
installation, servicing, and removal from installation involving the radioactive
material, its shielding or containment, are performed:
(a)
In accordance with the instructions provided by the labels; or
(b)
By a person holding an applicable specific license from the Department,
NRC or an Agreement State to perform such activities;
(4)
Shall maintain records showing compliance with the requirements of 3.6.4.3(2)
and 3.6.4.3(3).
(a)
The records shall show the results of tests.
(b)
The records also shall show the dates of performance of, and the names
of persons performing, testing, installation, servicing, and removal from
installation concerning the radioactive material, its shielding or
containment.
(c)
Records of tests for leakage of radioactive material required by 3.6.4.3(2)
shall be maintained for 3 years after the next required leak test is
performed or until the sealed source is transferred or disposed of.
(d)
Records of tests of the “on-off” mechanism and indicator required by
3.6.4.3(2) shall be maintained for 3 years after the next required test of
the “on-off” mechanism and indicator is performed or until the sealed
source is transferred or disposed of.
(e)
Records which are required by 3.6.4.3(3) shall be maintained for a period
of 3 years from the date of the recorded event or until the device is
transferred or disposed of;
(5)
Upon the occurrence of a failure of or damage to, or any indication of a possible
failure of or damage to, the shielding of the radioactive material or the “on-off”
mechanism or indicator, or upon the detection of 185 Bq (0.005 µCi) or more
removable radioactive material, shall immediately suspend operation of the
device and shall:
(a)
Not operate the device until it has been repaired by the manufacturer or
other person holding an applicable specific license from the Department,
NRC or an Agreement State to repair such devices;
(b)
Ensure that, if dispositioned, the device and any radioactive material
from the device is disposed of by transfer to a person authorized by an
applicable specific license to receive the radioactive material contained
in the device;
(c)
Within 30 days, furnish to the Department a report containing a brief
description of the event and the remedial action taken; and
(d)
In the case of detection of 185 Bq (0.005 microcurie) or more removable
radioactive material or failure of or damage to a source likely to result in
contamination of the premises or the environs, furnish to the Director of
the Hazardous Materials And Waste Management Division, within 30
days, a plan for ensuring that the premises and environs are acceptable
for unrestricted use.
(i)
Under these circumstances, the criteria set out in 4.61.2,
“Radiological Criteria For Unrestricted Use,” may be applicable,
as determined by the division on a case by case basis;
(6)
Shall not abandon the device containing radioactive material;
(7)
Shall not export the device except in accordance with 10 CFR Part 110 and shall
obtain written approval from NRC before transferring the device to any other
specific licensee not specifically identified in 3.6.4.3(8);
(8)
Except as provided in 3.6.4.3(9), shall transfer or dispose of the device
containing radioactive material:
(a)
Only by transfer to a specific licensee of the Department, NRC or an
Agreement State whose specific license authorizes receipt of the device;
and
(b)
Within 30 days after transfer or export, shall furnish to the Department a
report containing:
(i)
Identification of the device by manufacturer's (or initial
transferor’s) name, model number and serial number;
(ii)
The name, address and license number of the person receiving
the device;
(iii)
The date of the transfer;
(iv)
The identity of the radionuclide(s) present and activity present,
by assay or calculation;
(c)
Shall obtain written Department approval before transferring the device
to any other specific licensee not specifically identified in 3.6.4.3(8).
However, a holder of a specific license may transfer a device for
possession and use under its own specific license without prior approval,
if, the holder:
(i)
Verifies that the specific license authorizes the possession and
use, or applies for and obtains an amendment to the license
authorizing the possession and use;
(ii)
Removes, alters, covers, or clearly and unambiguously
augments the existing label (otherwise required by 3.6.4.3(1) of
this part) so that the device is labeled in compliance with Part 4,
Section 4.30; however the manufacturer, model number, and
serial number must be retained;
(iii)
Obtains the manufacturer’s or initial transferor’s information
concerning maintenance that would be applicable under the
specific license (such as leak testing procedures); and
(iv)
Reports the transfer under 3.6.4.3(8)(b).
(9)
Shall transfer the device to another general licensee only:
(a)
Where the device remains in use at a particular location.
In such case the transferor shall give the transferee a copy of this
regulation and any safety documents identified in the label on the device
and within 30 days of the transfer, report to the Department the
manufacturer's (or initial transferor’s) name and model number and serial
number of device transferred, the identity of the radionuclide(s) present
and assayed or calculated activity present, the transferee’s name and
mailing address for the location of use, and the name, title, and phone
number of the responsible individual identified by the transferee in
accordance with 3.6.4.3(12) to have knowledge of and authority to take
actions to ensure compliance with the appropriate regulations and
requirements; or
(b)
Where the device is held in storage by an intermediate person in the
original shipping container at its intended location of use prior to initial
use by a general licensee; and
(10)
Shall comply with the provisions of 4.51 and 4.52 for reporting radiation incidents,
theft, or loss of licensed material, but shall be exempt from the other
requirements of Parts 4 and 10;
(11)
Shall respond to written requests from the Department to provide information
relating to the general license within 30 calendar days of the date of the request,
or other time specified in the request.
(a)
If the general licensee cannot provide the requested information within
the allotted time, it shall, within that same time period, request a longer
period to supply the information by providing the director of the
Hazardous Materials and Waste Management Division a written
justification for the request;
(12)
Shall appoint an individual responsible for having knowledge of the appropriate
regulations and requirements and the authority for taking required actions to
comply with appropriate regulations and requirements.
(a)
The general licensee, through this individual, shall ensure the day-to-day
compliance with appropriate regulations and requirements; this
appointment does not relieve the general licensee of any of its
responsibility in this regard;
(13)
Shall register each device annually in accordance with 3.6.4.3(13)(a) and
3.6.4.3(13)(b), and shall pay the fee required by Part 12, if in possession of a
device containing at least 370 MBq (10 mCi) of cesium-137, 3.7 MBq (0.1 mCi) of
strontium-90, 37 MBq (1 mCi) of cobalt-60, 3.7 MBq (0.1 mCi) of radium-226, or
37 MBq (1 mCi) of americium 241 or any other transuranic (i.e., element with
atomic number greater than uranium (92)), based on the activity indicated on the
label. Each address for a location of use, as described in 3.6.4.3(13)(b)(iv) of this
section, represents a separate general licensee and requires a separate
registration and fee.
(a)
Registration must be done by verifying, correcting, and/or adding to the
information provided in a request for registration received from the
Department.
(i)
The registration information must be submitted to the
Department within 30 days of the date of the request for
registration or as otherwise indicated in the request.
(b)
In registering devices, the general licensee shall furnish the following
information and any other information specifically requested by the
Department:
(i)
Name and mailing address of the general licensee;
(ii)
Information about each device: the manufacturer (or initial
transferor), model number, serial number, the radioisotope and
activity (as indicated on the label);
(iii)
Name, title, and telephone number of the responsible person
designated as a representative of the general licensee under
3.6.4.3(12);
(iv)
Address or location at which the device(s) are used and/or
stored; for portable devices, the address of the primary place of
storage;
(v)
Certification by the responsible representative of the general
licensee that the information concerning the device(s) has been
verified through a physical inventory and checking of label
information; and
(vi)
Certification by the responsible representative of the general
licensee that they are aware of the requirements of the general
license.
(c)
A general licensee holding devices meeting the criteria of 3.6.4.3(13) is
subject to the bankruptcy notification requirement in 3.15.5.
(d)
Persons generally licensed by an Agreement State with respect to
devices meeting the criteria in paragraph 3.6.4.3(13) are not subject to
U.S. Nuclear Regulatory Commission registration requirements if the
devices are used in areas subject to NRC jurisdiction for a period less
than 180 days in any calendar year. The Commission will not request
registration information from such licensees.
(14)
Shall report changes to the mailing address for the location of use (including
change in name of general licensee) to the director of the hazardous materials
and waste management division within 30 days of the effective date of the
change.
(a)
For a portable device, a report of address change is only required for a
change in the device's primary place of storage.
(15)
May not hold a device that is not in use for longer than 2 years.
(a)
If a device with shutters is not being used, the shutter must be locked in
the closed position.
(b)
The testing required by 3.6.4.3(2) need not be performed during the
period of storage only.
(c)
However, when a device is put back into service or transferred to another
person, and has not been tested within the required test interval, the
device must be tested for leakage before use or transfer and the shutter
tested before use.
(d)
A device kept in standby for future use is excluded from the two-year
time limit if the general licensee performs quarterly physical inventories
of the device while the device is in standby.
3.6.4.4 The general license in 3.6.4.1 does not authorize the manufacture of devices containing
radioactive material.
3.6.4.5 The general license provided in 3.6.4.1 is subject to the provisions of 1.4 through 1.9,
3.15, 3.22, 3.23 and Part 17.
3.6.5
Luminous Safety Devices for Aircraft.
3.6.5.1 A general license is hereby issued to receive, acquire, possess, and use tritium or
promethium-147 contained in luminous safety devices for use in aircraft, provided:
(1)
Each device contains not more than 370 GBq (10 Ci) of tritium or 11.1 GBq (300
mCi) of promethium-147; and
(2)
Each device has been manufactured, assembled or imported in accordance with
a specific license issued by the NRC or each device has been manufactured or
assembled in accordance with the specifications contained in a specific license
issued by the Department or any Agreement State to the manufacturer or
assembler of such device pursuant to licensing requirements equivalent to those
in Section 32.53 of 10 CFR Part 32.
3.6.5.2 Persons who own, receive, acquire, possess, or use luminous safety devices pursuant to
the general license in 3.6.5.1 are exempt from the requirements of Parts 4 and 10 except
that they shall comply with the provisions of 4.51 and 4.52.
3.6.5.3 This general license does not authorize the manufacture, assembly, or repair of luminous
safety devices containing tritium or promethium-147.
3.6.5.4 This general license does not authorize the ownership, receipt, acquisition, possession or
use of promethium-147 contained in instrument dials.
3.6.5.5 This general license is subject to the provisions of 1.4 through 1.9, 3.15, 3.22, 3.23, and
Part 17.
3.6.6
Ownership of Radioactive Material.
3.6.6.1 A general license is hereby issued to own radioactive material without regard to quantity.
3.6.6.2 Notwithstanding any other provisions of this part, this general license does not authorize
the manufacture, production, transfer, receipt, possession or use of radioactive material.
3.6.7
Calibration and Reference Sources.
3.6.7.1 A general license is hereby issued to those persons listed below to own, receive, acquire,
possess, use, and transfer, in accordance with the provisions of 3.6.7.4 and 3.6.7.5,
americium-241 in the form of calibration or reference sources:
(1)
Any person who holds a specific license issued by the Department which
authorizes receipt, possession, use, and transfer of radioactive material; and
(2)
Any person who holds a specific license issued by the NRC which authorizes
receipt, possession, use, and transfer of special nuclear material.
3.6.7.2 A general license is hereby issued to own, receive, possess, use, and transfer plutonium
in the form of calibration or reference sources in accordance with the provisions of 3.6.7.4
and 3.6.7.5 to any person who holds a specific license issued by the Department which
authorizes the licensee to receive, possess, use, and transfer radioactive material.
3.6.7.3 A general license is hereby issued to own, receive, possess, use, and transfer radium
226 in the form of calibration or reference sources in accordance with the provisions of
3.6.7.4 and 3.6.7.5 to any person who holds a specific license issued by the Department
which authorizes the licensee to receive, possess, use, and transfer radioactive material.
3.6.7.4 The general licenses in 3.6.7.1, 3.6.7.2, and 3.6.7.3 apply only to calibration or reference
sources which have been manufactured or initially transferred in accordance with the
specifications contained in a specific license issued to the manufacturer or importer of the
sources by the NRC pursuant to Section 32.57 of 10 CFR Part 32 or Section 70.39 of 10
CFR Part 70 or which have been manufactured in accordance with the specifications
contained in a specific license issued to the manufacturer by the Department or any
Agreement State pursuant to licensing requirements equivalent to those contained in
Section 32.57 of 10 CFR Part 32 or Section 70.39 of 10 CFR Part 70.
3.6.7.5 The general licenses provided in 3.6.7.1, 3.6.7.2, and 3.6.7.3 are subject to the
provisions of 1.4 through 1.9, 3.15, 3.22, 3.23 and 3.24, and Parts 4 and 10. In addition,
persons who own, receive, acquire, possess, use, or transfer one or more calibration or
reference sources pursuant to these general licenses, shall:
(1)
Not possess at any one time, at any one location of storage or use, more than
185 kBq (5 µCi) of americium-241, 185 kBq (5 µCi) of plutonium, or 185 kBq (5
µCi) of radium-226 in such sources;
(2)
Not receive, possess, use, or transfer such source unless the source, or the
storage container, bears a label which includes one of the following statements,
as appropriate, or a substantially similar statement which contains the
information called for in one of the following statements, as appropriate:
(a)
The receipt, possession, use and transfer of this source, Model ___,
Serial No.__ are subject to a general license and the regulations of the
U.S. Nuclear Regulatory Commission or an Agreement State. Do not
remove this label.
CAUTION - RADIOACTIVE MATERIAL - THIS SOURCE CONTAINS
(AMERICIUM-241) (PLUTONIUM) (RADIUM-226).5 DO NOT TOUCH
RADIOACTIVE PORTION OF THIS SOURCE.
5 Showing only the name of the appropriate material.
______________________________________
Name of manufacturer or importer
(3)
Not transfer, abandon, or dispose of such source except by transfer to a person
authorized by a license from the Department, NRC or an Agreement State to
receive the source;
(4)
Store such source, except when the source is being used, in a closed container
adequately designed and constructed to contain americium-241, plutonium, or
radium-226 which might otherwise escape during storage; and
(5)
Not use such source for any purpose other than the calibration of radiation
detectors or the standardization of other sources.
3.6.7.6 These general licenses do not authorize the manufacture, import, or export of calibration
or reference sources containing americium-241, plutonium or radium-226.
3.6.8
General license for certain items and self-luminous products containing radium-226.
3.6.8.1 A general license is hereby issued to any person to acquire, receive, possess, use, or
transfer, in accordance with the provisions of 3.6.8.2 through 3.6.8.4., radium-226
contained in the following products manufactured prior to November 30, 2007.
(1)
Antiquities originally intended for use by the general public.
For the purposes of 3.6.8.1(1), antiquities mean products originally intended for
use by the general public and distributed in the late 19th and early 20th
centuries, such as radium emanator jars, revigators, radium water jars, radon
generators, refrigerator cards, radium bath salts, and healing pads.
(2)
Intact timepieces containing greater than 0.037 MBq (1 µCi), nonintact
timepieces, and timepiece hands and dials no longer installed in timepieces.
(3)
Luminous items installed in air, marine, or land vehicles.
(4)
All other luminous products, provided that no more than 100 items are used or
stored at the same location at any one time.
(5)
Small radium sources containing no more than 0.037 MBq (1 µCi) of radium-226.
For the purposes of 3.6.8.1(5), ‘‘small radium sources’’ means discrete survey
instrument check sources, sources contained in radiation measuring instruments,
sources used in educational demonstrations (such as cloud chambers and
spinthariscopes), electron tubes, lightning rods, ionization sources, static
eliminators, or as designated by the NRC.
3.6.8.2 Persons who acquire, receive, possess, use, or transfer radioactive material under the
general license issued in 3.6.8.1 are exempt from the provisions of Parts 4 and 10 of
these regulations, to the extent that the receipt, possession, use, or transfer of
radioactive material is within the terms of the general license; provided, however, that this
exemption shall not be deemed to apply to any such person specifically licensed under
this Part.
3.6.8.3 Any person who acquires, receives, possesses, uses, or transfers radioactive material in
accordance with the general license in 3.6.8.1 shall:
(1)
Notify the Department should there be any indication of possible damage to the
product so that it appears it could result in a loss of the radioactive material. A
report containing a brief description of the event, and the remedial action taken,
must be furnished to the Department within 30 days.
(2)
Not abandon products containing radium-226. The product, and any radioactive
material from the product, may only be disposed of according to Part 4, Section
4.39.2 of these regulations or by transfer to a person authorized by a specific
license to receive the radium-226 in the product or as otherwise approved by the
NRC or an Agreement State.
(3)
Not export products containing radium-226 except in accordance with 10 CFR
Part 110.
(4)
Dispose of products containing radium-226 at a disposal facility authorized to
dispose of radioactive material in accordance with any Federal or State solid or
hazardous waste law, including the Solid Waste Disposal Act, as authorized
under the Energy Policy Act of 2005, by transfer to a person authorized to
receive radium-226 by a specific license issued under this Part, or equivalent
regulations of the NRC or an Agreement State, or as otherwise approved by the
NRC or an Agreement State.
(5)
Respond to written requests from the Department to provide information relating
to the general license within 30 calendar days of the date of the request, or other
time specified in the request. If the general licensee cannot provide the
requested information within the allotted time, it shall, within that same time
period, request a longer period to supply the information by providing the
Department, a written justification for the request.
3.6.8.4. The general license in 3.6.8.1 does not authorize the manufacture, assembly,
disassembly, repair, or import of products containing radium-226, except that timepieces
may be disassembled and repaired.
3.6.9
General License for Use of Radioactive Material for Certain In Vitro Clinical or Laboratory
Testing.6
6 The New Drug provisions of the Federal Food, Drug, and Cosmetic Act also govern the availability and use of any specific
diagnostic drugs in interstate commerce.
3.6.9.1 A general license is hereby issued to any physician, veterinarian, clinical laboratory or
hospital to receive, acquire, possess, transfer or use, for any of the following stated tests,
in accordance with the provisions of 3.6.9.2, 3.6.9.3, 3.6.9.4, 3.6.9.5, and 3.6.9.6, the
following radioactive materials in prepackaged units for use in in vitro clinical or
laboratory tests not involving internal or external administration of radioactive material, or
the radiation therefrom, to human beings or animals:
(1)
Carbon-14, in units not exceeding 370 kBq (10 µCi) each;
(2)
Cobalt-57, in units not exceeding 370 kBq (10 µCi) each;
(3)
Hydrogen-3 (tritium), in units not exceeding 1.85 MBq (50 µCi) each;
(4)
Iodine-125, in units not exceeding 370 kBq (10 µCi) each;
(5)
Mock Iodine-125 reference or calibration sources, in units not exceeding 1.85
kBq (0.05 µCi) of iodine-129 and 185 Bq (0.005 µCi) of americium-241 each;
(6)
Iodine-131, in units not exceeding 370 kBq (10 µCi) each;
(7)
Iron-59, in units not exceeding 740 kBq (20 μCi) each; or
(8)
Selenium-75, in units not exceeding 370 kBq (10 µCi) each.
3.6.9.2 No person shall receive, acquire, possess, use or transfer radioactive material pursuant
to the general license established by 3.6.9.1 until the person has filed Department Form
R-27, “Certificate - In Vitro Testing with Radioactive Material Under General License”,
with the Department and received from the Department a validated copy of Department
Form R-27 with certification number assigned. The physician, veterinarian, clinical
laboratory or hospital shall furnish on Department Form R-27 the following information
and such other information as may be required by that form:
(1)
Name and address of the physician, veterinarian, clinical laboratory or hospital;
(2)
The location of use; and
(3)
A statement that the physician, veterinarian, clinical laboratory or hospital has
appropriate radiation measuring instruments to carry out in vitro clinical or
laboratory tests with radioactive material as authorized under the general license
in 3.6.9.1 and that such tests will be performed only by personnel competent in
the use of such instruments and in the handling of the radioactive material.
3.6.9.3 A person who receives, acquires, possesses or uses radioactive material pursuant to the
general license established by 3.6.9.1 shall comply with the following requirements.
(1)
The general licensee shall not possess at any one time, pursuant to the general
license in 3.6.9.1, at any one location of storage or use, a total amount of iodine
125, iodine 131, selenium 75, iron 59, and/or cobalt 57 in excess of 7.4 MBq (200
µCi).
(2)
The general licensee shall store the radioactive material, until used, in the
original shipping container or in a container providing equivalent radiation
protection.
(3)
The general licensee shall use the radioactive material only for the uses
authorized by 3.6.9.1.
(4)
The general licensee shall not transfer the radioactive material to a person who is
not authorized to receive it pursuant to a license issued by the Department, NRC
or any Agreement State nor transfer the radioactive material in any manner other
than in the unopened, labeled shipping container as received from the supplier.
(5)
The general licensee shall dispose of the Mock Iodine 125 reference or
calibration sources described in 3.6.9.1(5) as required by 4.33.
3.6.9.4 The general licensee shall not receive, acquire, possess, or use radioactive material
pursuant to 3.6.9.1:
(1)
Except as prepackaged units which are labeled in accordance with the provisions
of an applicable specific license issued pursuant to 3.12.8 or in accordance with
the provisions of a specific license issued by the NRC or any Agreement State
which authorizes the manufacture and distribution of iodine-125, iodine-131,
carbon-14, hydrogen-3 (tritium), iron-59, selenium-75, cobalt-57, or Mock Iodine-
125 to persons generally licensed under 3.6.9 or its equivalent; and
(2)
Unless one of the following statements, as appropriate, or a substantially similar
statement which contains the information called for in one of the following
statements, appears on a label affixed to each prepackaged unit or appears in a
leaflet or brochure which accompanies the package:
(a)
This radioactive material shall be received, acquired, possessed, and
used only by physicians, veterinarians, clinical laboratories or hospitals
and only for in vitro clinical or laboratory tests not involving internal or
external administration of the material, or the radiation therefrom, to
human beings or animals. Its receipt, acquisition, possession, use, and
transfer are subject to the regulations and a general license of the U.S.
Nuclear Regulatory Commission or an Agreement State.
______________________________________
Name of manufacturer
3.6.9.5 The physician, veterinarian, clinical laboratory or hospital possessing or using radioactive
material under the general license of 3.6.9.1 shall report in writing to the Department, any
changes in the information previously furnished using the “Certificate - In Vitro Testing
with Radioactive Material Under General License”, Department Form R-27. The report
shall be furnished within 30 days after the effective date of such change.
3.6.9.6 Any person using radioactive material pursuant to the general license of 3.6.9.1 is
exempt from the requirements of Part 4 and 10 with respect to radioactive material
covered by that general license, except that such persons using the Mock Iodine-125
described in 3.6.9.1(5) shall comply with the provisions of 4.33, 4.51 and 4.52.
3.6.10 Ice Detection Devices.
3.6.10.1
A general license is hereby issued to receive, acquire, possess, use, and transfer
strontium-90 contained in ice detection devices, provided each device contains not more
than 1.85 MBq (50 µCi) of strontium-90 and each device has been manufactured or
imported in accordance with a specific license issued by NRC or each device has been
manufactured in accordance with the specifications contained in a specific license issued
by the Department or an Agreement State to the manufacturer of such device pursuant to
licensing requirements equivalent to those in Section 32.61 of 10 CFR Part 32.
3.6.10.2
Persons who own, receive, acquire, possess, use, or transfer strontium-90
contained in ice detection devices pursuant to the general license in 3.6.10.1:
(1)
Shall, upon occurrence of visually observable damage, such as a bend or crack
or discoloration from overheating to the device, discontinue use of the device
until it has been inspected, tested for leakage and repaired by a person holding a
specific license from NRC or an Agreement State to manufacture or service such
devices; or shall dispose of the device pursuant to the provisions of 4.33;
(2)
Shall assure that all labels affixed to the device at the time of receipt, and which
bear a statement which prohibits removal of the labels, are maintained thereon;
and
(3)
Are exempt from the requirements of Parts 4 and 10 except that such persons
shall comply with the provisions of 4.33, 4.51, and 4.52.
3.6.10.3
This general license does not authorize the manufacture, assembly, disassembly
or repair of strontium-90 in ice detection devices.
3.6.10.4
This general license is subject to the provisions of 1.4 through 1.9, 3.15, 3.22,
3.23 and Part 17.
ADDITIONAL EXEMPTIONS
3.7
Carriers
Common and contract carriers, freight forwarders, warehousemen, and the U.S. Postal Service
are exempt from the regulations in this Part and Parts 5, 7, 16, 19, and 22 and the requirements
for a license set forth in Section 25-11-103, CRS to the extent that they transport or store
radioactive material in the regular course of carriage for another or storage incident thereto.
SPECIFIC LICENSES
3.8
Filing An Application for A Specific License.
3.8.1
Applications for specific licenses shall be filed on a form prescribed by the Department.
3.8.2
The Department may at any time after the filing of the original application, and before the
expiration of the license, require further statements in order to enable the Department to
determine whether the application should be granted or denied or whether a license should be
modified or revoked.
3.8.3
Each application shall be signed by the applicant or licensee or a person duly authorized to act
for and on the applicant's or licensee's behalf.
3.8.4
An application for a license may include a request for a license authorizing one or more activities.
3.8.5
In the application, the applicant may incorporate by reference information contained in previous
applications, statements, or reports filed with the Department provided such references are clear
and specific.
3.8.6
Applications and documents submitted to the Department may be made available for public
inspection except that the Department may withhold any document or part thereof from public
inspection pursuant to 24-72-204, CRS.
3.8.7
Pre-licensing Construction
3.8.7.1 An application for a license, or to amend or renew an existing license, for (1) source
material milling, (2) commercial waste storage, treatment or disposal by incineration, (3)
transfer for disposal of wastes from treatment or incineration, (4) commercial waste
disposal by land burial or by underground injection, or the (5) conduct of any other activity
within the licensing authority of the Department which the Department determines will
significantly affect the radiological quality of the human environment, shall be filed with
the Department at least nine (9) months prior to the anticipated commencement of
construction of the plant or facility in which the activity will be conducted or in accordance
with the requirements of Part 18 if applicable, and shall be accompanied by the
environmental assessment required by 3.8.8, unless an exemption from the requirement
of furnishing such assessment has been obtained from the Department.
3.8.7.2 No construction shall be commenced until the license has been issued.
3.8.7.3 For the purpose of 3.8.7 the terms “construction” and “commencement of construction”,
are defined in Part 1, 1.2.
3.8.8
Environmental Assessment.
3.8.8.1 In the case of an application for a license, or to amend or renew an existing license, for
(1) source material milling, (2) commercial waste storage, treatment or disposal by
incineration, (3) transfer for disposal of waste from incineration, (4) commercial waste
disposal by land burial or by underground injection, or for (5) the conduct of any other
activity which will affect the quality of the human environment by reason of exposure to
radiation, before “commencement of construction”, as defined in 3.8.7.3, of the plant or
facility in or at which the activity will be conducted, or in case of a renewal of such a
license, the applicant shall submit all information required under these regulations and
such other material as the Department may deem necessary.
(1)
Such information shall include the environmental assessment and other
information required by 3.8.8.2 to be submitted to assist the Department in the
evaluation of the short-term and long-range environmental impact of the project
and activity so that the Department may weigh environmental, economic,
technical, and other benefits against environmental costs, while considering
available alternatives.
(2)
In the event that an environmental assessment acceptable to the Department is
on file with the Department in regard to the specific licensed activity authorized
under an existing license, and upon request of the applicant to amend or renew
an existing license or at the initiation of the Department, the Department may
grant an exemption of the requirement to submit an additional environmental
assessment or require such amendment of the existing environmental
assessment as will demonstrate the environmental impact to result from the
proposed activity.
(3)
The request for exemption shall provide the Department with such information as
the Department requires of the applicant to demonstrate that no significant
environmental impact will result from the licensed activity.
3.8.8.2 An environmental assessment shall be required of the applicant and shall contain all
information deemed necessary by the Department as required by the Act.
(1)
Upon receipt of the environmental assessment or any amendment thereto, and of
any other documents required, the Department shall determine the necessity to
transmit and, if appropriate, shall transmit the same for review and comment to
Federal, State, and local agencies having expertise in and jurisdiction over the
proposed project and activity.
(2)
Written comments and reports of reviewing agencies shall be considered by the
Department in its decision-making review process on the license application
request.
(3)
If an environmental impact statement (EIS) is required of a Federal agency
pursuant to the National Environment Policy Act of 1969 (NEPA) and is provided
by such Federal agency, it shall be used by the Department in its decision-
making review process on the license application request.
(4)
The Department shall consider applicable regulations of Federal, State, and local
regulatory agencies and permit requirements thereof.
3.8.9
Except as provided in 3.8.9.3, 3.8.9.4, and 3.8.9.5, an application for a specific license to use
radioactive material in the form of a sealed source or in a device that contains the sealed source
must either:
3.8.9.1 Identify the source or device by manufacturer and model number as registered with the
NRC under 10 CFR Part 32.210 or with an Agreement State, or for a source or a device
containing radium-226 or accelerator produced radioactive material with an Agreement
State under provisions comparable to 10 CFR Part 32.210; or
3.8.9.2 Contain the information identified in 3.12.14.3; or
3.8.9.3 For sources or devices manufactured before October 23, 2012 that are not registered
with the NRC under 10 CFR Part 32.210 or with an Agreement State, and for which the
applicant is unable to provide all categories of information specified in 3.12.14.3, the
application must include:
(1)
All available information identified in 3.12.14.3 concerning the source, and, if
applicable, the device; and
(2)
Sufficient additional information to demonstrate that there is reasonable
assurance that the radiation safety properties of the source or device are
adequate to protect health and minimize danger to life and property. Such
information must include a description of the source or device, a description of
radiation safety features, the intended use and associated operating experience,
and the results of a recent leak test.
3.8.9.4 For sealed sources and devices allowed to be distributed without registration of safety
information in accordance with 3.12.14.7(1), the applicant may supply only the
manufacturer, model number, and radionuclide and quantity.
3.8.9.5 If it is not feasible to identify each sealed source and device individually, the applicant
may propose constraints on the number and type of sealed sources and devices to be
used and the conditions under which they will be used, in lieu of identifying each sealed
source and device.
3.8.10 An application from a medical facility, educational institution, or Federal facility to produce
Positron Emission Tomography (PET) radioactive drugs for noncommercial transfer to licensees
in its consortium authorized for medical use under Part 7 of these regulations or equivalent
Agreement State requirements shall include:
3.8.10.1
A request for authorization for the production of PET radionuclides or evidence of
an existing license issued under this Part or Agreement State requirements for a PET
radionuclide production facility within its consortium from which it receives PET
radionuclides.
3.8.10.2
Evidence that the applicant is qualified to produce radioactive drugs for medical
use by meeting one of the criteria in 3.12.10.1(2).
3.8.10.3
Identification of individual(s) authorized to prepare the PET radioactive drugs if
the applicant is a pharmacy, and documentation that each individual meets the
requirements of an authorized nuclear pharmacist as specified in 3.12.10.2(2).
3.8.10.4
Information identified in 3.12.10.1(3) on the PET drugs to be noncommercially
transferred to members of its consortium.
3.9
General Requirements for the Issuance of Specific Licenses.
A license application for a specific license will be approved if the Department determines that:
3.9.1
The applicant is qualified by reason of training and experience to use the material in question for
the purpose requested in accordance with these regulations in such a manner as to minimize
danger to public health and safety or property;
3.9.2
The applicant's proposed equipment, facilities, and procedures are adequate to minimize danger
to public health and safety or property and the applicant’s facilities are permanently located in
Colorado;
3.9.3
The issuance of the license will not be inimical to the health and safety of the public;
3.9.4
The applicant satisfies any applicable special requirements in parts 3, 5, 7, 16, 19, and 22; and
3.9.5
The applicant has established Department-approved financial assurance warranties in
accordance with the following requirements.
3.9.5.1 A signed executed original copy of each warranty required by this part shall be furnished
to and approved by the Department prior to the issuance of a new license, or any
amendment or renewal of an existing license.
3.9.5.2 The Department may require any licensee to furnish a decommissioning warranty in a
dollar amount determined by the Department as necessary to protect public health and
safety, to ensure corrective action during operation, to ensure decontamination and
decommissioning of a facility and disposal of radioactive materials in the event of
abandonment, default or inability of the licensee to meet the requirements of the Act,
these regulations, or the license.
3.9.5.3 The following specific licensees are required to furnish decommissioning warranties:
(1)
Each licensee authorized to possess and use greater than 370 MBq (10 mCi) of
source material in a readily dispersible form; and
(2)
Each licensee authorized to possess and use radioactive material with a half-life
greater than 120 days, in quantities:
(a)
Greater than 103 times the applicable quantity of Schedule 3B in
unsealed form. For a combination of isotopes if R divided by 103 is
greater than 1 (unity rule), where R is defined here as the sum of the
ratios of the quantity of each isotope to the applicable value in Schedule
3B.
(b)
Greater than 1010 times the applicable quantity of Schedule 3B in sealed
sources or plated foils. For a combination of isotopes if R divided by 1010
is greater than 1 (unity rule), where R is defined in 3.9.5.3(2)(a).
(c)
370 Bq (0.01 µCi) shall be used as the Schedule 3B value for any alpha
emitting radionuclide not listed in Schedule 3B, or mixtures of alpha
emitters of unknown composition, for the purpose of determining if the
quantity of licensed radioactive material requires a decommissioning
warranty or a decommissioning funding plan as defined in 3.9.6.
(3)
Former U.S. Atomic Energy Commission or NRC licensed facilities;
(4)
Radioactive waste collection and/or processing licensees;
(5)
Radioactive waste disposal licensees;
(6)
Source material milling licensees;
(7)
Ore refineries; and
(8)
Other persons with, or applicants for, a specific license as determined by the
Department.
3.9.5.4 Acceptable Financial Assurance Methods.
(1)
Financial assurance warranties shall contain provisions which are acceptable to
the Department for:
(a)
Defining the amount and term of the warranty;
(b)
Providing written notification to the Department by the warrantor at least
ninety (90) days prior to cancellation, termination, or revocation of the
warranty; and
(c)
Converting the warranty into cash upon forfeiture of the warranty, and
(2)
Financial assurance warranties shall be in the form of a cash deposit,
prepayment of a trust, escrow account, government fund, certificate of deposit, or
deposit of government securities.
(a)
Prepayment is the deposit prior to the start of operation into an account
segregated from licensee assets and outside the licensee’s
administrative control of cash or liquid assets such that the amount of
funds would be sufficient to pay decommissioning costs; or
(3)
Financial assurance warranties which involve a guarantee method to ensure that
costs will be paid should the licensee default shall be in a form as described
below:
(a)
A bond issued by a fidelity or surety company consistent with the
provisions of Section 25-11-110(6)(b)(l), CRS;
(b)
An irrevocable “letter of credit” or “line of credit” issued by a recognized
financial institution whose financial condition and commitment are
established to the satisfaction of the Department;
(c)
For a decommissioning warranty, a guarantee of funds by the applicant,
licensee, or parent company which satisfies the requirements listed
below. However, this self-guarantee shall not apply to uranium or thorium
milling licensees.
(i)
The Department may accept a parent company guarantee of
funds for decommissioning costs based upon a financial test of
the parent company and a written guarantee as contained in
Appendix 3F.
(ii)
The Department may accept an applicant or licensee guarantee
of funds for decommissioning costs based upon a financial test
of the applicant or licensee and a written guarantee as contained
in Appendix 3G.
(iii)
A guarantee by the applicant, licensee, or parent company may
not be used in combination with other financial methods to
satisfy the requirements of this section.
(iv)
A guarantee by the applicant or licensee may not be used in any
situation where the applicant or licensee has a parent company
holding majority control of the voting stock of the company; or
(4)
Financial assurance warranties which involve an external sinking fund shall be in
a form in which deposits are made at least annually, coupled with a surety
method or insurance, the value of which may decrease by the amount being
accumulated in the sinking fund.
(a)
An external sinking fund is a fund established and maintained by setting
aside funds periodically in an account segregated from licensee assets
and outside the licensee’s administrative control in which the total
amount of funds would be sufficient to pay decommissioning costs at the
time termination of operation is expected.
(b)
An external sinking fund may be in the form of a trust, escrow account,
government fund, certificate of deposit, or deposit of government
securities; or
(5)
Financial assurance warranties previously provided to any State, Federal and/or
local governing bodies concerning activities subject to license under these
regulations, where the amount, terms, and conditions of such financial assurance
warranties have been established to the satisfaction of the Department and in
accordance with the requirements of 3.9.5; or
(6)
Except for the guarantee of funds noted in 3.9.5.4(3), combinations of the above
may be used to establish an acceptable financial assurance warranty.
(7)
The term of the financial assurance warranty shall be open-ended or shall have
provisions for automatic renewal until termination of the license by the
Department, unless it can be demonstrated that another arrangement would
provide an equivalent level of assurance.
(8)
The value of the financial assurance warranty must not be dependent upon the
success, profitability, or continued operation of the licensed business or
operation.
3.9.5.5 The amount of funds to be provided by such decommissioning warranties shall be based
on Department-approved cost estimates and shall
(1)
Include the disposal of radioactive materials;
(2)
Include decontamination and decommissioning of buildings, facilities and the site
to levels which would allow unrestricted use of these areas upon
decommissioning;
(3)
Include the reclamation of tailings and/or waste disposal areas in accordance
with technical criteria delineated in Parts 3, 4 and/or 18, as appropriate;
(4)
Take into account total costs that would be incurred if an independent contractor
were hired to dispose of radioactive materials and perform decontamination,
decommissioning, and reclamation work, including:
(a)
The cost of removal and/or disposal of radioactive material, or a
radioactivity-inducing machine, which is or would be generated, stored,
processed or otherwise present at the facility or site; and
(b)
The probable extent of contamination through the possession or use of
radioactive material, at or adjacent to the facility or site, and the probable
cost of removal of such contamination; and
(5)
Include reasonable administrative costs, including indirect costs, incurred by the
Department in conducting or overseeing the decontamination, decommissioning,
and disposal activities, and to cover the Department's reasonable attorney costs
that may be incurred in successfully revoking, foreclosing, or realizing the
decommissioning warranties established by the licensee in accordance with Part
3.
3.9.5.6 The licensee shall provide in writing to the Department, no later than June 30th of each
calendar year, an annual report demonstrating proof of the value of existing financial
warranties and any licensee-proposed changes to the financial assurance warranties,
including updated decommissioning funding plans, cost estimates, or the type of
warranty. The annual report shall describe any changes in operations, estimated costs, or
any other circumstances that may affect the amount of the required financial assurance
warranties, including any increased or decreased costs attributable to inflation.
3.9.5.7 Each licensee's financial assurance warranties shall be subject to review annually by the
Department to assure the continued adequacy of each warranty. Public notice of the
submittal of the licensee's annual report shall be posted on the Department's web site
and published by the licensee in the local paper of general circulation. Any person may
submit written comments to the Department concerning the adequacy of any financial
assurance warranties. The act of submitting such comments does not provide a right to
administrative appeal concerning the financial assurance warranties.
3.9.5.8 The Department will determine if the licensee must adjust the amount of the warranty to
account for increases or decreases in cost estimates resulting from:
(1)
Inflation or deflation;
(2)
Changes in engineering plans;
(3)
Activities performed;
(4)
Spills, leakage or migration of radioactive material producing additional
contamination in onsite subsurface material that must be remediated to meet
applicable remediation criteria;
(5)
Waste inventory increasing above the amount previously estimated;
(6)
Waste disposal costs increasing above the amount previously estimated;
(7)
Facility modifications;
(8)
Changes in authorized possession limits;
(9)
Actual remediation costs that exceed the previous cost estimate;
(10)
Onsite disposal; and
(11)
Changes in any other conditions affecting disposal, decontamination, and
decommissioning costs.
3.9.5.9 Regardless of whether reclamation (disposal, decontamination and decommissioning) is
phased through the life of the licensed operations or takes place at the end of operations,
an appropriate portion of surety liability must be retained until final compliance with the
reclamation plan is determined by the Department.
3.9.5.10
The appropriate portion of surety liability retained until final compliance with the
reclamation plan is determined will be at least sufficient at all times to cover the costs of
decommissioning and reclamation of the areas that are expected to be disturbed before
the next license renewal. The term of the surety mechanism must be open ended, unless
it can be demonstrated that another arrangement would provide an equivalent level of
assurance. This assurance would be provided with a surety instrument which is written
for a specified time (e.g., 5 years) and which must be automatically renewed unless the
surety notifies the beneficiary (the NRC or the Department) and the principal (the
licensee) with reasonable time (e.g., 90 days) before the renewal date of their intention
not to renew. In such a situation the surety requirement still exists and the licensee would
be required to submit an acceptable replacement surety within a brief time to allow at
least 60 days for the regulatory agency to collect.
3.9.5.11
Proof of forfeiture must not be necessary to collect the surety. In the event the
licensee can not provide an acceptable replacement surety within the required time, the
surety shall be automatically collected before its expiration. The surety instrument must
provide for collection of the full face amount immediately on demand without reduction for
any reason, except for trustee fees and expenses provided for in a trust agreement, and
that the surety will not refuse to make full payment. The conditions described previously
would have to be clearly stated on any surety instrument which is not open ended, and
must be agreed to by all parties. Financial surety arrangements generally acceptable to
the Department are:
(1)
Trust funds;
(2)
Surety bonds;
(3)
Irrevocable letters of credit; and
(4)
Combinations of the financial surety arrangements or other types of
arrangements as may be approved by the Department. If a trust is not used, then
a standby trust must be set up to receive funds in the event the NRC or
Department exercises its right to collect the surety. The surety arrangement and
the surety or trustee, as applicable, must be acceptable to the Department. Self
insurance, or any arrangement which essentially constitutes self insurance (e.g.,
a contract with a State or Federal agency), will not satisfy the surety requirement
because this provides no additional assurance other than that which already
exists through license requirements.
3.9.5.12
With the approval of the Department, a licensee may reduce the amount of a
decommissioning warranty as decommissioning activities are completed in accordance
with an approved decommissioning plan and/or to reflect current site conditions and
license authorizations.
3.9.5.13
The licensee shall have sixty days after the date of written notification by the
Department of a required adjustment to establish a warranty fulfilling all new
requirements unless granted an extension by the Department. If the licensee disputes the
amount of the required financial assurance warranties, the licensee may request a
hearing to be conducted in accordance with section 24-4-105, CRS.
3.9.5.14
If the licensee requests a hearing, no new material ore or other radioactive
material may be brought on site for processing or disposal and no new radioactive
material may be processed until the licensee's dispute over the financial assurance
warranty is resolved, unless the licensee posts a bond in a form approved by the
Department equal to the amount in dispute.
LONG-TERM CARE WARRANTY
3.9.5.15
In addition to the decommissioning warranty required by 3.9.5.2, the Department
may require any licensee to provide a long-term care warranty if the licensed facility will
remain a disposal site for radioactive materials subsequent to the termination of the
license, or the license will be terminated using criteria in 4.61.3 or 4.61.4.
(1)
Except as provided in 3.9.5.15(2), the following specific licensees are required to
provide long-term care warranties:
(a)
Radioactive waste disposal licensees;
(b)
Commercial radioactive waste handling and/or packaging licensees;
(c)
Source material milling licensees; and
(d)
Formerly U.S. Atomic Energy Commission or U.S. Nuclear Regulatory
Commission-licensed facilities;
(2)
A long-term care warranty is not required for a licensee identified in 3.9.5.15(1) if
the disposition of radioactive materials by the licensee is made in such a manner
as the Department determines does not require long-term monitoring and
maintenance of the site.
(3)
The long-term care warranty shall be in a form as described in 3.9.5.4.
(4)
The amount of funds to be provided by such long-term care warranties shall be
based on Department-approved cost estimates and must be enough that with an
assumed one percent annual real interest rate, the annual interest earnings will
be sufficient to cover the annual costs of site surveillance, including reasonable
administrative costs incurred, in perpetuity, subsequent to the termination of the
license.
(a)
For each source material mill licensee, the long-term care warranty must
have a minimum value equivalent to $250,000 in 1978 dollars.
(i)
The value of the long-term care warranty shall be adjusted
annually to recognize inflation.
(ii)
The inflation rate to be used for this adjustment is that indicated
by the change in the consumer price index published by the U.S.
Department of Labor, Bureau of Labor Statistics.
(iii)
The Department may use other indicators of the inflation rate if
reasonable; provided, however, that the license shall not
terminate unless the amount of the long-term care warranty is
acceptable to the licensing agency and site caretaker.
(b)
Cost estimates for facilities and sites requiring long-term care
subsequent to license termination are to be based on the final disposition
of wastes such that ongoing active maintenance is not necessary to
preserve isolation.
(i)
It is expected that, as a minimum, annual site inspections shall
be conducted to confirm the integrity of the stabilized waste
systems and to determine the need, if any, for maintenance
and/or monitoring.
(ii)
Cost estimates shall be adjusted if more frequent site inspections
are required based on an evaluation of a particular site.
(c)
For sites decommissioned in accordance with the provisions of 4.61.3 or
4.61.4, cost estimates for long-term care subsequent to license
termination must be sufficient to enable the Department, a responsible
government agency, or an independent third party to:
(i)
Perform periodic site inspections no less frequently than each
five years;
(ii)
Assure the continuation of institutional controls; and
(iii)
Assume responsibilities and carry out any necessary control and
maintenance of the site. Cost estimates shall be adjusted if more
frequent site inspections are required based on an evaluation of
a particular site and the institutional controls established for that
site.
(5)
Whenever the Department determines that a licensee's disposal,
decommissioning and decontamination requirements have been satisfied,
provisions shall be made for transferring custody of the site and the long-term
care warranty funds for that license in accordance with the act.
(a)
If the value of the long-term care warranty funds exceeds the amount
required by the government agency overseeing the long-term care of the
site, then all such excess amounts shall be returned to the licensee.
3.9.6
Decommissioning Funding Plan Required.
3.9.6.1 Each applicant for and holder of a license authorizing the possession and use unsealed
radioactive materials with half-life greater than 120 days and in quantities greater than
105 times the applicable quantity of Schedule 3B, shall establish a Department-approved
decommissioning funding plan to assure the availability of funds for decommissioning
activities conducted over the life of the licensed facility. 370 Bq (0.01 µCi) shall be used
as the Schedule 3B value for any alpha emitting radionuclide not listed in Schedule 3B, or
mixtures of alpha emitters of unknown composition. A decommissioning funding plan is
also required for licensees authorized a combination of isotopes if R divided by 105 is
greater than 1 (unity rule), where R is defined in 3.9.5.3(2)(a).
3.9.6.2 Each holder of, or applicant for, any specific license authorizing the possession and use
of sealed sources or plated foils of half-life greater than 120 days and in quantities
greater than 1012 times the applicable quantity in Schedule 3B shall establish a
Department-approved decommissioning funding plan to assure the availability of funds
for decommissioning activities conducted over the life of the licensed facility. 370 Bq
(0.01 µCi) shall be used as the Schedule 3B value for any alpha emitting radionuclide not
listed in Schedule 3B, or mixtures of alpha emitters of unknown composition. The
decommissioning funding plan is also required for licensees authorized for a combination
of isotopes if R divided by 1012 is greater than 1 (unity rule), where R is defined as in
3.9.5.3(2)(a).
3.9.6.3 Waste collectors and waste processors, as defined in Part 4, Appendix D, shall establish
a Department-approved decommissioning funding plan to assure the availability of funds
for decommissioning activities conducted over the life of the licensed facility.
(1)
The decommissioning funding plan must include the cost of disposal of the
maximum radioactivity (becquerel or curie) of radioactive material permitted by
the license, and the cost of disposal of the maximum quantity, by volume, of
radioactive material that could be present at the licensee’s facility at any time, in
addition to the cost to remediate the licensee’s site to meet the license
termination criteria of Part 4.
3.9.6.4 Each decommissioning funding plan must be submitted for review and approval by the
Department and must contain:
(1)
A detailed cost estimate for decommissioning, in an amount reflecting:
(a)
The cost of an independent contractor to perform all decommissioning
activities;
(b)
The cost of meeting the 4.61.2 criteria for unrestricted use, provided that,
if the applicant or licensee can demonstrate its ability to meet the
provisions of 4.61.3 for restricted use, the cost estimate may be based
on meeting the 4.61.3 restricted use criteria;
(c)
The volume of onsite subsurface material containing residual
radioactivity that will require remediation to meet the criteria for license
termination; and
(d)
An adequate contingency factor.
(i)
Identification of and justification for using the key assumptions
contained in the detailed cost estimate;
(ii)
A description of the method of assuring funds for
decommissioning as required in this section, including means for
adjusting cost estimates and associated funding levels
periodically over the life of the facility.
(iii)
A certification by the licensee that financial assurance for
decommissioning has been provided in the amount of the cost
estimate for decommissioning; and
(iv)
A signed original, or if permitted, a copy, of the financial
instrument obtained to satisfy the requirements of this section
(unless a previously submitted and accepted financial instrument
continues to cover the cost estimate for decommissioning).
3.9.6.5 At the time of license renewal and at intervals not to exceed three years, the
decommissioning funding plan must be resubmitted with adjustments as necessary to
account for changes in costs and the extent of contamination. If the amount of financial
assurance will be adjusted downward, this can not be done until the updated
decommissioning funding plan is approved. The decommissioning funding plan must
update the information submitted with the original or prior approved plan, and must
specifically consider the effect of the following events on decommissioning costs:
(1)
Spills of radioactive material producing additional residual radioactivity in onsite
subsurface material;
(2)
Waste inventory increasing above the amount previously estimated;
(3)
Waste disposal costs increasing above the amount previously estimated;
(4)
Facility modifications;
(5)
Changes in authorized possession limits;
(6)
Actual remediation costs that exceed the previous cost estimate;
(7)
Onsite disposal; and
(8)
Use of a settling pond.
3.9.6.6 The decommissioning funding plan must also include a certification by the licensee that
funding for decommissioning activities has been provided for in the amount of the cost
estimate for decommissioning.
(1)
For an applicant, this certification may state that the appropriate assurance will
be obtained after the application has been approved and the license issued, but
prior to the receipt or possession of radioactive material.
(2)
A signed original of the financial instrument shall be submitted to the Department.
3.9.7
In the case of an application for a license for (1) source material milling, (2) commercial waste
storage, treatment or disposal by incineration, (3) transfer for disposal of waste from incineration,
(4) commercial waste disposal by land burial or by underground injection, or for (5) the conduct of
any other activity which the Department determines will significantly affect the quality of the
human environment, the Department, before commencement of construction, on the basis of
information filed and evaluations made, has concluded, after weighing the environmental,
economic, technical and other benefits against environmental costs and considering available
alternatives, that the action called for is the issuance of the proposed license with any appropriate
conditions to protect environmental values.
3.9.7.1 Commencement of construction prior to this conclusion is grounds for denial of a license
to possess and use source and byproduct material in the plant or facility.
3.9.8
Commencement of construction prior to the issuance of a license, or of an amendment or renewal
thereof, or of an exemption under the requirements of 3.8.7, may be grounds for denial of such
license, amendment or renewal.
3.9.9
Reserved.
3.9.10 License Hearings.
3.9.10.1
There shall be an opportunity for public hearings to be held in the following
circumstances in accordance with the procedures in 24-4-104 and -105, CRS. and this
paragraph:
(1)
Prior to the licensing or leasing of state-owned property for the concentration,
storage or permanent disposal of radioactive materials.
(2)
For each proposed license, five-year license renewal, or license amendment
pertaining to a uranium recovery facility's receipt of material as specified in Part
18 of these regulations.
3.9.11 Contingency Plans
3.9.11.1
Each application to possess radioactive materials in unsealed form, on foils or
plated sources, or sealed in glass in excess of the quantities in Schedule 3E - “Quantities
of Radioactive Materials Requiring Consideration of the Need for an Emergency Plan for
Responding to a Release”, must contain either:
(1)
An evaluation, as described in 3.9.11.2, showing that the projected dose to a
person offsite due to a release of radioactive materials would not exceed 0.01 Sv
(1 rem) effective dose equivalent or 0.05 Sv (5 rem) to the thyroid; or
(2)
A contingency plan for responding to a release of radioactive material.
3.9.11.2
In evaluating the total effective dose equivalent to an individual pursuant to
3.9.11.1(1):
(1)
The radioactive material is physically separated so that only a portion could be
involved in an accident;
(2)
All or part of the radioactive material is not subject to release during an accident
because of the way it is stored or packaged;
(3)
The release fraction in the respirable size range is predicted to be lower than the
release fraction shown in Schedule 3E due to the chemical or physical form of
the material;
(4)
The solubility of the radioactive material would reduce the dose received;
(5)
Facility design or engineered safety features in the facility would cause the
release fraction to be lower than shown in Schedule 3E.
(6)
Operating restrictions or procedures would prevent a release fraction as large as
that shown in Schedule 3E.
3.9.11.3
A contingency plan for responding to a release of radioactive material submitted
under 3.9.11.1(2) must include the following information, in separate sections having
each page numbered and labeled with a revision date and revision number:
(1)
Facility description - a brief description of the licensee's facility and surroundings.
(2)
Types of accidents - a n identification of each type of accident involving
radioactive material for which actions by licensee staff or offsite response
organizations will be needed to protect members of the public.
(3)
Classification of accidents - a method for classifying and declaring each alert or
site area emergency, as defined in Part 1.
(4)
Detection of accidents - identification of the means of detecting each type of
accident in a timely manner.
(5)
Mitigation of consequences - a brief description of the means and equipment for
mitigating the consequences of each type of accident, including those provided to
protect workers onsite, and a description of the program for maintaining the
equipment.
(6)
Assessment of releases - a brief description of the methods and equipment to
assess releases of radioactive materials.
(7)
Responsibilities - a brief description of the responsibilities of licensee personnel
should an accident occur, including identification of personnel responsible for
promptly notifying offsite response organizations and the Department; also
responsibilities for developing, maintaining, and updating the plan.
(8)
Notification and coordination.
(a)
A commitment to and a brief description of the means to promptly notify
offsite response organizations and request offsite assistance, including
medical assistance for the treatment of contaminated injured onsite
workers when appropriate.
(b)
A control point must be established.
(c)
The notification and coordination must be planned so that unavailability
of some personnel, parts of the facility, and some equipment will not
prevent the notification and coordination.
(d)
The licensee shall also commit to notify the Department immediately
after notification of the appropriate offsite response organizations and not
later than one hour after the licensee declares an emergency.
(9)
Information to be communicated - a brief description of the types of information
on facility status, radioactive releases, and recommended protective actions, if
necessary, to be given to offsite response organizations and to the Department.
(10)
Training.
(a)
A brief description of the frequency, performance objectives and plans
for the training that the licensee will provide workers on how to respond
to an emergency including any special instructions and orientation tours
the licensee would offer to fire, police, medical and other emergency
personnel.
(b)
The training shall familiarize personnel with site-specific emergency
procedures.
(c)
Also, the training shall thoroughly prepare site personnel for their
responsibilities in the event of accident scenarios postulated as most
probable for the specific site, including the use of team training for such
scenarios.
(11)
Safe shutdown - a brief description of the means of restoring the facility to a safe
condition after an accident.
(12)
Exercises.
(a)
Provisions for conducting quarterly communications checks with offsite
response organizations and biennial onsite exercises to test response to
simulated emergencies.
(b)
Quarterly communications checks with offsite response organizations
must include the check and update of all necessary telephone numbers.
(c)
The licensee shall invite offsite response organizations to participate in
the biennial exercises.
(d)
Participation of offsite response organizations in biennial exercises
although recommended is not required.
(e)
Exercises must use accident scenarios postulated as most probable for
the specific site and the scenarios shall not be known to most exercise
participants.
(f)
The licensee shall critique each exercise using individuals not having
direct implementation responsibility for the plan.
(g)
Critiques of exercises must evaluate the appropriateness of the plan,
emergency procedures, facilities, equipment, training of personnel, and
overall effectiveness of the response.
(h)
Deficiencies found by the critiques must be corrected.
(13)
Hazardous chemicals - a certification that the applicant has met its
responsibilities under the Emergency Planning and Community Right-To-Know
Act of 1986, Title III, Pub. L. 99-499, if applicable to the applicant's activities at
the proposed place of use of the radioactive material.
3.9.11.4
The licensee shall allow the offsite response organizations expected to respond
in case of an accident 60 days to comment on the licensee's emergency plan before
submitting it to the Department.
(1)
The licensee shall provide any comments received within 60 days to the
Department with the emergency plan.
3.10
Additional Requirements for Issuance of Specific Licenses for Use of Unsealed
Radioactive Material.
3.10.1 In addition to the requirements set forth in 3.9, applicants for licenses authorizing the possession
and use of unsealed radioactive materials shall include in the application a description of the
facility and procedures for operation which
3.10.1.1
Minimize to the extent practicable, contamination of the facility and environment;
3.10.1.2
Facilitate eventual decommissioning; and
3.10.1.3
Minimize, to the extent practicable, the generation of radioactive waste.
3.10.2 Licensees shall, to the extent practical, conduct operations to minimize the introduction of
residual radioactivity into the site, including the subsurface, in accordance with the existing
radiation protection requirements in Part 4, Section 4.5 and radiological criteria for license
termination in Part 4, Section 4.61 of the regulations.
3.11
Special Requirements for Specific Licenses of Broad Scope.
3.11.1 This section prescribes requirements for the issuance of specific licenses of broad scope for
radioactive material and certain regulations governing holders of the types of broad licenses set
forth below.7
7 Authority to transfer possession or control by the manufacturer, processor, or producer of any equipment, device, commodity, or
other product containing byproduct material whose subsequent possession, use, transfer, and disposal by all other persons are
exempted from regulatory requirements may be obtained only from the U.S. Nuclear Regulatory Commission, Washington, D.C.
20555.
3.11.1.1
A “Type A specific license of broad scope” is a specific license authorizing
receipt, acquisition, ownership, possession, use and transfer of any chemical or physical
form of the radioactive material specified in the license, but not exceeding quantities
specified in the license, for any authorized purpose.
(1)
The quantities specified are usually in the multicurie range.
3.11.1.2
A “Type B specific license of broad scope” is a specific license authorizing
receipt, acquisition, possession, use and transfer of any chemical or physical form of
radioactive material specified in Schedule 3D of this part, for any authorized purpose.
(1)
The possession limit for a Type B license of broad scope, if only one radionuclide
is possessed thereunder, is the quantity specified for that radionuclide in
Schedule 3D, Column I.
(2)
If two or more radionuclides are possessed thereunder, the possession limit for
each is determined as follows: For each radionuclide, determine the ratio of the
quantity possessed to the applicable quantity specified in Schedule 3D, Column
I, for that radionuclide.
(3)
The sum of the ratios for all radionuclides possessed under the license shall not
exceed unity.
3.11.1.3
A “Type C specific license of broad scope” is a specific license authorizing
receipt, acquisition, ownership, possession, use, and transfer of any chemical or physical
form of radioactive material specified in Schedule 3D of this part, for any authorized
purpose.
(1)
The possession limit for a Type C license of broad scope, if only one radionuclide
is possessed thereunder, is the quantity specified for that radionuclide in
Schedule 3D, Column II.
(2)
If two or more radionuclides are possessed thereunder, the possession limit is
determined for each as follows: For each radionuclide, determine the ratio of the
quantity possessed to the applicable quantity specified in Schedule 3D, Column
II, for that radionuclide.
(3)
The sum of the ratios for all radionuclides possessed under the license shall not
exceed unity.
3.11.2 An application for a Type A specific license of broad scope will be approved if:
3.11.2.1
The applicant satisfies the general requirements specified in 3.9;
3.11.2.2
The applicant has engaged in a reasonable number of activities involving the use
of radioactive material; and
3.11.2.3
The applicant has established administrative controls and provisions relating to
organization and management, procedures, record keeping, material control and
accounting, and management review that are necessary to assure safe operations,
including:
(1)
The establishment of a radiation safety committee composed of such persons as
a radiation safety officer, a representative of management, and persons trained
and experienced in the safe use of radioactive material;
(2)
The appointment of a radiation safety officer who is qualified by training and
experience in radiation protection, and who is available for advice and assistance
on radiation safety matters; and
(3)
The establishment of appropriate administrative procedures to assure:
(a)
Control of procurement and use of radioactive material;
(b)
Completion of safety evaluations of proposed uses of radioactive
material which take into consideration such matters as the adequacy of
facilities and equipment, training and experience of the user, the
operating or handling procedures; and
(c)
Review, approval, and recording by the radiation safety committee of
safety evaluations of proposed uses prepared in accordance with
3.11.2.3(3)(b) prior to use of the radioactive material.
3.11.3 An application for a Type B specific license of broad scope will be approved if:
3.11.3.1
The applicant satisfies the general requirements specified in 3.9; and
3.11.3.2
The applicant has established administrative controls and provisions relating to
organization and management, procedures, record keeping, material control and
accounting, and management review that are necessary to assure safe operations,
including:
(1)
The appointment of a radiation safety officer who is qualified by training and
experience in radiation protection, and who is available for advice and assistance
on radiation safety matters; and
(2)
The establishment of appropriate administrative procedures to assure;
(a)
Control of procurement and use of radioactive material;
(b)
Completion of safety evaluations of proposed uses of radioactive
material which take into consideration such matters as the adequacy of
facilities and equipment, training and experience of the user, and the
operating or handling procedures; and
(c)
Review, approval, and recording by the radiation safety officer of safety
evaluations of proposed uses prepared in accordance with 3.11.3.2(2)(b)
prior to use of the radioactive material.
3.11.4 An application for a Type C specific license of broad scope will be approved if:
3.11.4.1
The applicant satisfies the general requirements specified in 3.9;
3.11.4.2
The applicant submits a statement that radioactive material will be used only by,
or under the direct supervision of, individuals who have received:
(1)
A college degree at the bachelor level, or equivalent training and experience, in
the physical or biological sciences or in engineering, and
(2)
At least 40 hours of training and experience in the safe handling of radioactive
material, and in the characteristics of ionizing radiation, units of radiation dose
and quantities, radiation detection instrumentation, and biological hazards of
exposure to radiation appropriate to the type and forms of radioactive material to
be used; and
3.11.4.3
The applicant has established administrative controls and provisions relating to
procurement of radioactive material, procedures, record keeping, material control and
accounting, and management review necessary to assure safe operations.
3.11.5 Specific licenses of broad scope are subject to the following conditions:
3.11.5.1
Unless specifically authorized, persons licensed pursuant to 3.11 shall not:
(1)
Conduct tracer studies in the environment involving direct release of radioactive
material;
(2)
Receive, acquire, own, possess, use; or transfer devices containing 3.7 PBq (100
kCi) or more of radioactive material in sealed sources used for irradiation of
materials;
(3)
Conduct activities for which a specific license issued by the Department under
Part 3, 5, or 7 is required; or
(4)
Add or cause the addition of radioactive material to any food, beverage,
cosmetic, drug, or other product designed for ingestion or inhalation by, or
application to, a human being.
3.11.5.2
Each Type A specific license of broad scope issued under this part shall be
subject to the condition that radioactive material possessed under the license may only
be used by, or under the direct supervision of, individuals approved by the licensee's
radiation safety committee.
3.11.5.3
Each Type B specific license of broad scope issued under this part shall be
subject to the condition that radioactive material possessed under the license may only
be used by, or under the direct supervision of, individuals approved by the licensee's
radiation safety officer.
3.11.5.4
Each Type C specific license of broad scope issued under this part shall be
subject to the condition that radioactive material possessed under the license may only
be used by, or under the direct supervision of, individuals who satisfy the requirements of
3.11.4.
3.12
Special Requirements for a Specific License to Manufacture, Assemble, Repair, or
Distribute Commodities, Products, or Devices which Contain Radioactive Material.
3.12.1 A licensee authorized to introduce radioactive material into a product or material owned by or in
the possession of the licensee or another to be transferred to persons exempt under 3.3.1.1 shall
meet the requirements of 10 CFR Part 32.11 and any other applicable NRC requirement.
3.12.2 No person may introduce byproduct material into a product or material knowing or having reason
to believe that it will be transferred to persons exempted pursuant to 3.3.2, under 10 CFR Part
30.14 or equivalent regulations of an Agreement State, except in accordance with a license
issued under 10 CFR Part 32.8
8 Authority to transfer possession or control by the manufacturer, processor, or producer of any equipment, device, commodity, or
other product containing byproduct material whose subsequent possession, use, transfer, and disposal by all other persons are
exempted from regulatory requirements may be obtained only from the U.S. Nuclear Regulatory Commission, Washington, D.C.
20555.
3.12.2.3
Each person licensed under 3.12.2 shall maintain records identifying, by name
and address, each person to whom radioactive material is transferred for use under
3.3.2, and stating the kinds and quantities of radioactive material transferred. An annual
summary report stating the total quantity of each radionuclide transferred under the
specific license shall be filed with the Department. Each report shall cover the year
ending June 30, and shall be filed within 30 days thereafter. If no transfers of radioactive
material have been made pursuant to 3.12.2 during the reporting period, the report shall
so indicate.
3.12.3 RESERVED.
3.12.4 Licensing the Manufacture and Distribution of Devices to Persons Generally Licensed Under
3.6.4.
3.12.4.1
An application for a specific license to manufacture, or initially transfer devices
containing radioactive material, excluding special nuclear material, to persons generally
licensed under 3.6.4 or equivalent regulations of NRC or an Agreement State will be
approved if:
(1)
The applicant satisfies the general requirements of 3.9;
(2)
The applicant submits sufficient information relating to the design, manufacture,
prototype testing, quality control, labels, proposed uses, installation, servicing,
leak testing, operating and safety instructions, and potential hazards of the
device to provide reasonable assurance that:
(a)
The device can be safely operated by persons not having training in
radiological protection;
(b)
Under ordinary conditions of handling, storage, and use of the device,
the radioactive material contained in the device will not be released or
inadvertently removed from the device, and it is unlikely that any person
will receive in any period of 1 calendar quarter a dose in excess of 10
percent of the limits specified in 4.6.1; and
(c)
Under accident conditions such as fire and explosion associated with
handling, storage, and use of the device, it is unlikely that any person
would receive an external radiation dose or dose commitment in excess
of the following organ doses:
(i)
Whole body; head and trunk; active blood-forming organs;
gonads; or lens of eye: 150 mSv (15 rem)
(ii)
Hands and forearms; feet and ankles; localized areas of skin
averaged over areas no larger than 1 square centimeter: 2 Sv
(200 rem)
(iii)
Other organs: 500 mSv (50 rem); and
(3)
Each device bears a durable, legible, clearly visible label or labels approved by
the Department, which contain in a clearly identified and separate statement:
(a)
Instructions and precautions necessary to assure safe installation,
operation, and servicing of the device; documents such as operating and
service manuals may be identified in the label and used to provide this
information;
(b)
The requirement, or lack of requirement, for leak testing, or for testing
any “on-off” mechanism and indicator, including the maximum time
interval for such testing, and the identification of radioactive material by
isotope, quantity of radioactivity, and date of determination of the
quantity; and
(c)
The information called for in one of the following statements, as
appropriate, in the same or substantially similar form:
(i)
The receipt, possession, use, and transfer of this device, Model
___, Serial No. ___9, are subject to a general license or the
equivalent and the regulations of the U.S. Nuclear Regulatory
Commission or an Agreement State. This label shall be
maintained on the device in a legible condition. Removal of this
label is prohibited.
CAUTION - RADIOACTIVE MATERIAL
________________________________
Name of manufacturer or distributor
9 The model, serial number, and name of the manufacturer or distributor may be omitted from this label provided the information is
elsewhere specified in labeling affixed to the device.
(ii)
The receipt, possession, use, and transfer of this device,
Model___, Serial No. ___10, are subject to a general license or
the equivalent, and the radiation regulations. This label shall be
maintained on the device in a legible condition. Removal of this
label is prohibited.
CAUTION - RADIOACTIVE MATERIAL
________________________________
Name of manufacturer or distributor
10 The model, serial number, and name of the manufacturer or distributor may be omitted from this label provided the information is
elsewhere specified in labeling affixed to the device.
(4)
Each device having a separable source housing that provides the primary
shielding for the source also bears, on the source housing, a durable label
containing the device model number and serial number, the isotope and quantity,
the words, “Caution-Radioactive Material,” the radiation symbol prescribed in
4.27 and the name of the manufacturer or initial distributor.
(5)
The device has been registered in the Sealed Source and Device Registry.
3.12.4.2
In the event the applicant desires that the device be required to be tested at
intervals longer than 6 months, either for proper operation of the “on-off” mechanism and
indicator, if any, or for leakage of radioactive material or for both, the applicant shall
include in the application sufficient information to demonstrate that such longer interval is
justified by performance characteristics of the device or similar devices and by design
features which have a significant bearing on the probability or consequences of leakage
of radioactive material from the device or failure of the “on-off” mechanism and indicator.
3.12.4.3
In determining the acceptable interval for the test for leakage of radioactive
material, the Department will consider information which includes, but is not limited to:
(1)
Primary containment or source capsule;
(2)
Protection of primary containment;
(3)
Method of sealing containment;
(4)
Containment construction materials;
(5)
Form of contained radioactive material;
(6)
Maximum temperature withstood during prototype tests;
(7)
Maximum pressure withstood during prototype tests;
(8)
Maximum quantity of contained radioactive material;
(9)
Radiotoxicity of contained radioactive material; and
(10)
Operating experience with identical devices or similarly designed and
constructed devices.
3.12.4.4
In the event the applicant desires that the general licensee under 3.6.4, or under
equivalent regulations of NRC or an Agreement State, be authorized to install the device,
collect the sample to be analyzed by a specific licensee for leakage of radioactive
material, service the device, test the “on-off” mechanism and indicator, or remove the
device from installation, the applicant shall include in the application written instructions
to be followed by the general licensee, estimated calendar quarter doses associated with
such activity or activities, and bases for such estimates.
(1)
The submitted information shall demonstrate that performance of such activity or
activities by an individual untrained in radiological protection, in addition to other
handling, storage, and use of devices under the general license, is unlikely to
cause that individual to receive a calendar quarter dose in excess of 10 percent
of the limits specified in 4.6.1.
3.12.4.5
Each person licensed under 3.12.4 to distribute devices to generally licensed
person shall:
(1)
Before a device is transferred, furnish information specified in this paragraph to
each person to whom a device is to be transferred, or in the case of a transfer
through an intermediate person, to the intended user prior to initial transfer to the
intermediate person, including:
(a)
A copy of the general license contained in 3.6.4 and a copy of the
general license contained in the NRC or Agreement State regulation
equivalent to 3.6.4;
(b)
A copy of sections 3.6 and 4.40 through 4.52;
(c)
A list of the services that can only be performed by a specific licensee;
(d)
Information on acceptable disposal options including estimated costs of
disposal;
(e)
An indication that federal policy is to issue high civil penalties for
improper disposal; and
(f)
The name or title, address, and phone number of the contact at the
transferee’s NRC or Agreement State location.
(2)
Report to the Department all transfers of such devices to persons for use under
the general license in 3.6.4 and all receipts of such devices.
(a)
Such a report to the Department shall include:
(i)
The identity of each general licensee by name and mailing
address for the location of use; if there is no mailing address for
the location of use, an alternate address for the general licensee
shall be submitted along with information on the actual location
of use;
(ii)
The name, title, and phone number of the person identified by
the general licensee as having knowledge of and authority to
take required actions to ensure compliance with the appropriate
regulations and requirements;
(iii)
The date of transfer;
(iv)
The type, model number, and serial number of the device
transferred; and
(v)
The quantity and type of radioactive material contained in the
device.
(b)
If one or more intermediate persons will temporarily possess the device
at the intended place of use before its possession by the user, the report
must include the same information for both the intended user and each
intermediate person, and clearly designate the intermediate person(s).
(c)
For devices received from a 3.6.4 general licensee, the report must
include the identity of the general licensee by name and address, the
type, model number, and serial number of the device received, the date
of receipt, and, in the case of devices not initially transferred by the
reporting licensee, the name of the manufacturer or initial transferor.
(d)
If the licensee makes changes to a device possessed by a 3.6.4 general
licensee, such that the label must be changed to update required
information, the report must identify the general licensee, the device, and
the changes to information on the device label.
(e)
The report must cover each calendar quarter, must be filed within 30
days of the end of the calendar quarter, and must clearly indicate the
period covered by the report.
(f)
The report must clearly identify the specific licensee submitting the report
and include the license number of the specific licensee.
(g)
If no transfers have been made to or from persons generally licensed
under 3.6.4 during the reporting period, the report must so indicate.
(3)
Furnish clear and legible reports to other agencies, containing all of the data
required by Form 653, “Transfers of Industrial Devices Report”, including:
(a)
Report the information specified in 3.12.4.5(2) to NRC for all transfers of
such devices to persons for use under NRC general license in Section
31.5 of 10 CFR Part 31.
(b)
Report the information specified in 3.12.4.5 (2) to the responsible State
agency for all transfers of devices manufactured and distributed pursuant
to 3.12.4 for use under a general license in that State's regulations
equivalent to 3.6.4.
(4)
Maintain all information concerning transfers and receipts of devices that
supports the reports required by this section for a period of 3 years following the
date of the recorded event.
3.12.5 Special Requirements for the Manufacture, Assembly, Repair or Initial Transfer of Luminous
Safety Devices for Use in Aircraft.
3.12.5.1
An application for a specific license to manufacture, assemble, repair or initially
transfer luminous safety devices containing tritium or promethium-147 for use in aircraft,
for distribution to persons generally licensed under 3.6.5 will be approved if:
(1)
The applicant satisfies the general requirements specified in 3.9; and
(2)
The applicant satisfies the requirements of Sections 32.53, 32.54, 32.55, and
32.56 of 10 CFR Part 32, or their equivalent.
(3)
The device has been registered in the Sealed Source and Device Registry.
3.12.6 Special Requirements for License to Manufacture or initially transfer Calibration Sources
Containing Americium–241, Plutonium or Radium-226 for Distribution to Persons Generally
Licensed Under 3.6.7.
3.12.6.1
An application for a specific license to manufacture calibration and reference
sources containing americium-241, plutonium or radium-226 to persons generally
licensed under 3.6.7 will be approved if:
(1)
The applicant satisfies the general requirement of 3.9; and
(2)
The applicant satisfies the requirements of Sections 32.57, 32.58, and 32.59 of
10 CFR Part 32 and Section 70.39 of 10 CFR Part 70 or their equivalent.
3.12.7 Reserved.
3.12.8 Manufacture and Distribution of Radioactive Material for Certain In Vitro Clinical or Laboratory
Testing Under General License.
3.12.8.1
An application for a specific license to manufacture or distribute radioactive
material for use under the general license of 3.6.9 will be approved if:
(1)
The applicant satisfies the general requirements specified in 3.9.
(2)
The radioactive material is to be prepared for distribution in prepackaged units of:
(a)
Carbon-14 in units not exceeding 370 kBq (10 µCi) each.
(b)
Cobalt-57 in units not exceeding 370 kBq (10 µCi) each.
(c)
Hydrogen-3 (tritium) in units not exceeding 1.85 MBq (50 µCi) each.
(d)
Iodine-125 in units not exceeding 370 kBq (10 µCi) each.
(e)
Mock Iodine-125 in units not exceeding 1.85 kBq (0.05 µCi) of iodine-129
and 185 kBq (0.005 µCi) of americium-241 each.
(f)
Iodine-131 in units not exceeding 370 kBq (10 µCi) each.
(g)
Iron-59 in units not exceeding 740 kBq (20 µCi) each.
(h)
Selenium-75 in units not exceeding 370 kBq (10 µCi) each.
(3)
Each prepackaged unit bears a durable, clearly visible label:
(a)
Identifying the radioactive contents as to chemical form and radionuclide,
and indicating that the amount of radioactivity does not exceed 370 kBq
(10 µCi) of iodine-125, iodine-131, carbon-14, cobalt-57, or selenium-75;
1.85 MBq (50 µCi) of hydrogen-3 (tritium); 740 kBq (20 µCi) of iron-59; or
Mock Iodine-125 in units not exceeding 1.85 kBq (0.05 µCi) of iodine-129
and 185 Bq (0.005 µCi) of americium-241 each; and
(b)
Displaying the radiation caution symbol described in 4.27.1and the
words, “CAUTION, RADIOACTIVE MATERIAL”, and “Not for Internal or
External Use in Humans or Animals”.
(4)
One of the following statements, as appropriate, or a substantially similar
statement which contains the information called for in one of the following
statements, appears on a label affixed to each prepackaged unit or appears in a
leaflet or brochure which accompanies the package:
(a)
This radioactive material may be received, acquired, possessed, and
used only by physicians, veterinarians, clinical laboratories or hospitals
and only for in vitro clinical or laboratory tests not involving internal or
external administration of the material, or the radiation therefrom, to
human beings or animals. Its receipt, acquisition, possession, use, and
transfer are subject to the regulations and a general license of NRC or
an Agreement State.
___________________________________
Name of manufacturer
(5)
The label affixed to the unit, or the leaflet or brochure which accompanies the
package, contains adequate information as to the precautions to be observed in
handling and storing such radioactive material. In the case of the Mock Iodine-
125 reference or calibration source, the information accompanying the source
must also contain directions to the licensee regarding the waste disposal
requirements set out in 4.33.
3.12.9 Licensing the Manufacture or initial transfer of Ice Detection Devices.
3.12.9.1
An application for a specific license to manufacture and distribute ice detection
devices to persons generally licensed under 3.6.10 will be approved if:
(1)
The applicant satisfies the general requirements of 3.9; and
(2)
The criteria of Sections 32.61, and 32.62 of 10 CFR Part 32 are met.
(3)
The device has been registered in the Sealed Source and Device Registry.
3.12.10 Manufacture, Preparation, or Transfer for Commercial Distribution of Radioactive Drugs for
Medical Use.
3.12.10.1
An application for a specific license to manufacture, prepare, or transfer for
commercial distribution radioactive drugs containing radioactive material for use by
persons authorized under Part 7 will be approved if:
(1)
The applicant satisfies the general requirements specified in 3.9;
(2)
The applicant submits evidence that the applicant is at least one of the following:
(a)
Registered or licensed with the U.S. Food and Drug Administration
(FDA) as the owner or operator of a drug establishment that engages in
the manufacture, preparation, propagation, compounding, or processing
of a drug under 21 CFR Part 207.17(a);
(b)
Registered or licensed with the State Board of Pharmacy as a drug
manufacturer;
(c)
Licensed as a pharmacy by the State Board of Pharmacy;
(d)
Operating as a nuclear pharmacy within a Federal medical institution; or
(e)
A Positron Emission Tomography (PET) drug production facility
registered with the State Board of Pharmacy.
(3)
The applicant submits information on the radionuclide; the chemical and physical
form; the maximum activity per vial, syringe, generator, or other container of the
radioactive drug; and the shielding provided by the packaging to show it is
appropriate for safe handling and storage of the radioactive drugs by medical use
licensees; and
(4)
The applicant has procedures which commit to the following labeling
requirements:
(a)
A label is affixed to each transport radiation shield, whether it is
constructed of lead, glass, plastic, or other material of a radioactive drug
to be transferred for commercial distribution.
(i)
The label must include the radiation symbol prescribed in 4.27
and the words “CAUTION, RADIOACTIVE MATERIAL” or
“DANGER, RADIOACTIVE MATERIAL”; the name of the
radioactive drug or its abbreviation; and the quantity of
radioactivity at a specified date and time.
(ii)
For radioactive drugs with a half-life greater than 100 days, the
time may be omitted.
(b)
A label is affixed to each syringe, vial, or other container used to hold a
radioactive drug to be transferred for commercial distribution. The label
must include:
(i)
The radiation symbol prescribed in 4.27 and the words
“CAUTION, RADIOACTIVE MATERIAL” or “DANGER,
RADIOACTIVE MATERIAL”; and
(ii)
An identifier that ensures that the syringe, vial or other container
can be correlated with the information on the transport radiation
shield label.
3.12.10.2
A licensee described by 3.12.10.1(2)(c) or 3.12.10.1(2)(d):
(1)
May prepare radioactive drugs for medical use, as defined in Part 1, Section 1.2
and Part 7, provided that the radioactive drug is prepared by either:
(a)
An authorized nuclear pharmacist, as specified in 3.12.10.2(2) or
3.12.10.2(4), or
(b)
An individual under the direct supervision of an authorized nuclear
pharmacist as specified in Part 7, Section 7.10;
(2)
May allow a pharmacist to work as an authorized nuclear pharmacist if:
(a)
This individual qualifies as an Authorized Nuclear Pharmacist as defined
in Part 7, Section 7.2;
(b)
This individual meets the requirements specified in Part 7 Appendix 7C2
and Section 7.65, and the licensee has received an approved license
amendment identifying this individual as an authorized nuclear
pharmacist; or
(c)
This individual is designated as an authorized nuclear pharmacist in
accordance with 3.12.10.2(4).
(3)
The actions authorized in 3.12.10.2(1) and 3.12.10.2(2) are permitted in spite of
more restrictive language in license conditions.
(4)
May designate a pharmacist (as defined in Part 7, Section 7.2) as an authorized
nuclear pharmacist if:
(a)
The individual was a nuclear pharmacist preparing only radioactive drugs
containing accelerator-produced radioactive material, and
(b)
The individual practiced at a pharmacy at a Government agency or
Federally recognized Indian Tribe before November 30, 2007 or at all
other pharmacies before August 8, 2009, or an earlier date as noticed by
the NRC.
(5)
Shall provide to the Department:
(a)
A copy of each individual’s certification by a specialty board whose
certification process has been recognized by the NRC or an Agreement
State as specified in Part 7, Appendix 7C1; or
(b)
The Department, NRC or Agreement State license, or
(c)
NRC master materials licensee permit, or
(d)
The permit issued by a licensee or NRC master materials permittee of
broad scope or the authorization from a commercial nuclear pharmacy
authorized to list its own authorized nuclear pharmacist, or
(e)
Documentation that only accelerator-produced radioactive materials
were used in the practice of nuclear pharmacy at a Government agency
or Federally recognized Indian Tribe before November 30, 2007 or at all
other locations of use before August 8, 2009, or an earlier date as
noticed by the NRC; and
(f)
A copy of the State pharmacy licensure or registration, no later than 30
days after the date that the licensee allows, under 3.12.10.2(2)(a) and
3.12.10.2(2)(c), the individual to work as an authorized nuclear
pharmacist.
3.12.10.3
A licensee shall possess and use instrumentation to measure the radioactivity of
radioactive drugs.
(1)
The licensee shall have procedures for use of the instrumentation.
(2)
The licensee shall measure, by direct measurement or by combination of
measurements and calculations, the amount of radioactivity in dosages of alpha-,
beta- or photon-emitting radioactive drugs prior to transfer for commercial
distribution.
(3)
In addition, the licensee shall:
(a)
Perform tests before initial use, periodically, and following repair, on
each instrument for accuracy, linearity and geometry dependence, as
appropriate for the use of the instrument; and make adjustments when
necessary; and
(b)
Check each instrument for constancy and proper operation at the
beginning of each day of use.
3.12.10.4
A licensee shall satisfy the labeling requirements in 3.12.10.1(4).
3.12.10.5
Nothing in this section relieves the licensee from complying with applicable FDA,
Federal, and state requirements governing radioactive drugs.
3.12.11 Reserved.
3.12.12 Manufacture and Distribution of Sources or Devices Containing Radioactive Material for Medical
Use.
3.12.12.1
An application for a specific license to manufacture and distribute sources and
devices containing radioactive material to persons licensed pursuant to Part 7 for use as
a calibration, transmission, or reference source or for the uses listed in Part 7, Sections
7.19, 7.40, 7.42, 7.48 and 7.62 will be approved if:
(1)
The applicant satisfies the general requirements in 3.9 of this part;
(2)
The applicant submits sufficient information regarding each type of source or
device pertinent to an evaluation of its radiation safety, including:
(a)
The radioactive material contained, its chemical and physical form, and
amount,
(b)
Details of design and construction of the source or device,
(c)
Procedures for, and results of, prototype tests to demonstrate that the
source or device will maintain its integrity under stresses likely to be
encountered in normal use and accidents,
(d)
For devices containing radioactive material, the radiation profile of a
prototype device,
(e)
Details of quality control procedures to assure that production sources
and devices meet the standards of the design and prototype tests,
(f)
Procedures and standards for calibrating sources and devices,
(g)
Legend and methods for labeling sources and devices as to their
radioactive content, and
(h)
Instructions for handling and storing the source or device from the
radiation safety standpoint; these instructions are to be included on a
durable label attached to the source or device or attached to a
permanent storage container for the source or device; provided, that
instructions which are too lengthy for such label may be summarized on
the label and printed in detail on a brochure which is referenced on the
label;
(3)
The label affixed to the source or device, or to the permanent storage container
for the source or device, contains information on the radionuclide, quantity, and
date of assay, and a statement that the source or device is licensed by the
Department for distribution to persons licensed pursuant to Part 7, Sections 7.40
and 7.42 or under equivalent licenses of NRC or an Agreement State, provided
that such labeling for sources which do not require long term storage may be on
a leaflet or brochure which accompanies the source;
(4)
The source or device has been registered in the Sealed Source and Device
Registry.
3.12.12.2
In the event the applicant desires that the source or device be required to be
tested for leakage of radioactive material at intervals longer than 6 months, the applicant
shall include in the application sufficient information to demonstrate that such longer
interval is justified by performance characteristics of the source or device or similar
sources or devices and by design features that have a significant bearing on the
probability or consequences of leakage of radioactive material from the source; and
3.12.12.3
In determining the acceptable interval for test of leakage of radioactive material,
the Department will consider information that includes, but is not limited to:
(1)
Primary containment or source capsule,
(2)
Protection of primary containment,
(3)
Method of sealing containment,
(4)
Containment construction materials,
(5)
Form of contained radioactive material,
(6)
Maximum temperature withstood during prototype tests,
(7)
Maximum pressure withstood during prototype tests,
(8)
Maximum quantity of contained radioactive material,
(9)
Radiotoxicity of contained radioactive material, and
(10)
Operating experience with identical sources or devices or similarly designed and
constructed sources or devices.
3.12.13 Requirements for License to Manufacture and Distribute Industrial Products Containing Depleted
Uranium for Mass-Volume Applications.
3.12.13.1
An application for a specific license to manufacture industrial products and
devices containing depleted uranium for use pursuant to 3.5.5 or equivalent regulations
of NRC or an Agreement State will be approved if:
(1)
The applicant satisfies the general requirements specified in 3.9;
(2)
The applicant submits sufficient information relating to the design, manufacture,
prototype testing, quality control procedures, labeling or marking, proposed uses,
and potential hazards of the industrial product or device to provide reasonable
assurance that possession, use, or transfer of the depleted uranium in the
product or device is not likely to cause any individual to receive in any period of 1
calendar quarter a radiation dose in excess of 10 percent of the limits specified in
4.6.1; and
(3)
The applicant submits sufficient information regarding the industrial product or
device and the presence of depleted uranium for a mass-volume application in
the product or device to provide reasonable assurance that unique benefits will
accrue to the public because of the usefulness of the product or device.
3.12.13.2
In the case of an industrial product or device whose unique benefits are
questionable, the Department will approve an application for a specific license under
3.12.13 only if the product or device is found to combine a high degree of utility and low
probability of uncontrolled disposal and dispersal of significant quantities of depleted
uranium into the environment.
3.12.13.3
The Department may deny any application for a specific license under 3.12.13 if
the end use(s) of the industrial product or device cannot be reasonably foreseen.
3.12.13.4
Each person licensed pursuant to 3.12.13.1 shall:
(1)
Maintain the level of quality control required by the license in the manufacture of
the industrial product or device, and in the installation of the depleted uranium
into the product or device;
(2)
Label or mark each unit to:
(a)
Identify the manufacturer of the product or device and the number of the
license under which the product or device was manufactured, the fact
that the product or device contains depleted uranium, and the quantity of
depleted uranium in each product or device; and
(b)
State that the receipt, possession, use, and transfer of the product or
device are subject to a general license or the equivalent and the
regulations of NRC or an Agreement State;
(3)
Assure that the depleted uranium before being installed in each product or device
has been impressed with the following legend clearly legible through any plating
or other covering: “Depleted Uranium”;
(4)
Furnish a copy of the general license:
(a)
Contained in 3.5.5 and a copy of Department Form R-52 to each person
to whom the specific licensee transfers depleted uranium in a product or
device for use pursuant to the general license contained in 3.5.5, or
(b)
Contained in an NRC or Agreement State regulation equivalent to 3.5.5
and a copy of an NRC or Agreement State certificate, or alternatively,
furnish a copy of the general license contained in 3.5.5 and a copy of
Department Form R-52 to each person to whom the specific licensee
transfers depleted uranium in a product or device for use pursuant to the
general license of NRC or an Agreement State, with a note explaining
that use of the product or device is regulated by NRC or an Agreement
State under requirements substantially the same as those in 3.5.5;
(5)
Report to the Department all transfers of industrial products or devices to
persons for use under the general license in 3.5.5.
(a)
Such report shall identify each general licensee by name and address,
an individual by name and/or position who may constitute a point of
contact between the Department and the general licensee, the type and
model number of device transferred, and the quantity of depleted
uranium contained in the product or device.
(b)
The report shall be submitted within 30 days after the end of each
calendar quarter in which such a product or device is transferred to the
generally licensed person.
(c)
If no transfers have been made to persons generally licensed under
3.5.5 during the reporting period, the report shall so indicate;
(6)
Report to NRC all transfers of industrial products or devices to persons for use
under NRC general license in Section 40.25 of 10 CFR Part 40.
(a)
Such report shall identify each general licensee by name and address,
an individual by name and/or position who may constitute a point of
contact between the agency and the general licensee, the type and
model number of device transferred, and the quantity of depleted
uranium contained in the product or device.
(b)
The report shall be submitted within 30 days after the end of each
calendar quarter in which such a product or device is transferred to the
generally licensed person.
(c)
If no transfers have been made to U.S. Nuclear Regulatory Commission
licensees during the reporting period, this information shall be reported to
NRC;
(7)
Report to the responsible State agency all transfers of devices manufactured and
distributed pursuant to 3.12.13 for use under a general license in that State's
regulations equivalent to 3.5.5,
(a)
Such report shall identify each general licensee by name and address,
an individual by name and/or position who may constitute a point of
contact between the agency and the general licensee, the type and
model number of device transferred, and the quantity of depleted
uranium contained in the product or device.
(b)
The report shall be submitted within 30 days after the end of each
calendar quarter in which such a product or device is transferred to the
generally licensed person.
(c)
If no transfers have been made general licensees within a particular
agreement state during the reporting period, this information shall be
reported to the responsible Agreement State agency upon the request of
that agency;
(8)
Keep records showing the name, address, and point of contact for each general
licensee to whom the specific licensee transfers depleted uranium in industrial
products or devices for use pursuant to the general license provided in 3.5.5 or
equivalent regulations of NRC or an Agreement State.
(a)
The records shall be maintained for a period of 2 years and shall show
the date of each transfer, the quantity of depleted uranium in each
product or device transferred, and compliance with the report
requirements of this section.
3.12.14 Registration of Product Information.
3.12.14.1
Any manufacturer or initial distributor of a sealed source or device containing a
sealed source may submit a request to the Department for evaluation of radiation safety
information about its product and for the product registration.
3.12.14.2
The request for review must be sent to the Radiation Program Manager,
Hazardous Materials and Waste Management Division, Colorado Department of Public
Health and Environment, 4300 Cherry Creek Drive South, Denver, Colorado 80246-1530.
3.12.14.3
The request for review of a sealed source or device must include sufficient
information about the design, manufacture, prototype testing, quality control program,
labeling, proposed uses and leak testing and, for a device, the request must also include
sufficient information about installation, service and maintenance, operating and safety
instructions, and its potential hazards, to provide reasonable assurance that the radiation
safety properties of the source or device are adequate to protect health and minimize
danger to life and property.
3.12.14.4
The Department normally evaluates a sealed source or device using radiation
safety criteria in accepted industry standards.
(1)
If these standards and criteria do not readily apply to a particular case, the
Department formulates reasonable standards and criteria with the help of the
manufacturer or distributor.
(2)
The Department shall use criteria and standards sufficient to ensure that the
radiation safety properties of the device or sealed source are adequate to protect
health and minimize danger to life and property. Subpart A of 10 CFR Part 32
includes specific criteria that apply to certain exempt products and 3.12.4, 3.12.5,
3.12.6, 3.12.8, and 3.12.9 of this part includes specific criteria applicable to
certain generally licensed devices. Sections 3.12.10 and 3.12.12 include specific
provisions that apply to certain specifically licensed items.
3.12.14.5
After completion of the evaluation, the Department issues a certificate of
registration to the person making the request. The certificate of registration
acknowledges the availability of the submitted information for inclusion in an application
for specific license proposing use of the product or concerning use under an exemption
from licensing or general license as applicable for the category of certificate.
3.12.14.6
The person submitting the request for evaluation and registration of safety
information about the product shall manufacture and distribute the product in accordance
with:
(1)
The statements and representations, including quality control program, contained
in the request; and
(2)
The provisions of the certificate of registration.
3.12.14.7
Authority to manufacture or initially distribute a sealed source or device to
specific licensees may be provided in the license without the issuance of a certificate of
registration in the following cases:
(1)
Calibration and reference sources containing no more than:
(a)
37 MBq (1 mCi), for beta and/or gamma emitting radionuclides; or
(b)
0.37 MBq (10 μCi), for alpha emitting radionuclides; or
(2)
The intended recipients are qualified by training and experience and have
sufficient facilities and equipment to safely use and handle the requested quantity
of radioactive material in any form in the case of unregistered sources or, for
registered sealed sources contained in unregistered devices, are qualified by
training and experience and have sufficient facilities and equipment to safely use
and handle the requested quantity of radioactive material in unshielded form, as
specified in their licenses; and
(a)
The intended recipients are licensed under 3.11 or comparable
provisions of NRC or an Agreement State; or
(b)
The recipients are authorized for research and development; or
(c)
The sources and devices are to be built to the unique specifications of
the particular recipient and contain no more than 740 GBq (20 Ci) of
tritium or 7.4 GBq (200 mCi) of any other radionuclide.
3.12.14.8
After the certificate is issued, the Department may conduct an additional review
as it determines is necessary to ensure compliance with current regulatory standards. In
conducting its review, the Department will complete its evaluation in accordance with
criteria specified in this section. The Department may request such additional information
as it considers necessary to conduct its review and the certificate holder shall provide the
information as requested.
3.12.15 Inactivation of certificates of registration of sealed sources and devices
3.12.15.1
A certificate holder who no longer manufactures or initially transfers any of the
sealed source(s) or device(s) covered by a particular certificate issued by the Department
shall request inactivation of the registration certificate. Such a request must be made to
the Department and must normally be made no later than two years after initial
distribution of all of the source(s) or device(s) covered by the certificate has ceased.
However, if the certificate holder determines that an initial transfer was in fact the last
initial transfer more than two years after that transfer, the certificate holder shall request
inactivation of the certificate within 90 days of this determination and briefly describe the
circumstances of the delay.
3.12.15.2
If a distribution license is to be terminated in accordance with 3.16 the licensee
shall request inactivation of its registration certificates associated with that distribution
license before the Department will terminate the license. Such a request for inactivation
of certificate(s) must indicate that the license is being terminated and include the
associated specific license number.
3.12.15.3
A specific license to manufacture or initially transfer a source or device covered
only by an inactivated certificate no longer authorizes the licensee to initially transfer such
sources or devices for use. Servicing of devices must be in accordance with any
conditions in the certificate, including in the case of an inactive certificate.
3.13
Third-Party Method.
3.13.1 If the applicant consents, the Department may enter into third party agreements for the applicant
to engage and pay for the services of a third party contractor to prepare the environmental impact
analysis required under 18.4 and/or to furnish an opinion of independent experts, satisfactory to
the Department, in respect to the completeness and adequacy of any information or data
furnished by the applicant and on any aspect of the applicant's project or effects thereof.
3.13.2 In proceeding under the third party agreement, the Department shall carry out the following
practices:
3.13.2.1
Such contractor shall be chosen solely by the Department.
3.13.2.2
The Department shall manage the contract.
3.13.2.3
The consultant shall be selected based on the consultant's ability relevant and
applicable work experience and an absence of conflict of interest. Third party contractors
will be required to execute a disclosure statement signifying they have no financial or
other conflicting interest in the outcome of the project.
3.13.2.4
The Department shall specify the information to be developed and supervise the
gathering, analysis and presentation of the information.
3.13.2.5
The Department shall have sole authority for approval and modification of the
statement, analysis, and conclusions included in third party's report.
3.13.3 When the license applicant pays for a third party agreement, the monies paid for the consultant
shall not be charged as part of the fees required under Part 12.
3.14
Issuance of a Specific License.
3.14.1 Upon a determination that an application meets the requirements of the Act and the regulations of
the Department, the Department will issue a specific license authorizing the proposed activity in
such form and containing such conditions and limitations as it deems appropriate or necessary.
3.14.2 The Department may incorporate in any license at the time of issuance, or thereafter by
appropriate rule, regulation, or order, such additional requirements and conditions with respect to
the licensee's receipt, possession, use, and transfer of radioactive material subject to this part, as
it deems appropriate or necessary in order to:
3.14.2.1
Minimize danger to public health and safety or property;
3.14.2.2
Require such reports and the keeping of such records, and to provide for such
inspections of activities under the license as may be appropriate or necessary; and
3.14.2.3
Prevent loss or theft of material subject to this part.
3.14.3 Whenever the Department denies an application for a new license or a license renewal, the
Department will notify the applicant in writing stating the grounds for denial
3.14.3.1
Upon denial, the applicant may request a hearing pursuant to Sections 24-4-104
and 24-4-105, CRS.
3.15
Specific Terms and Conditions of License.
3.15.1 Each license issued pursuant to this part shall be subject to all the provisions of the Act, now or
hereafter in effect, and to all rules, regulations, and orders of the Department.
3.15.2 Inalienability of Licenses.
3.15.2.1
No license issued or granted under this part and no right to possess or utilize
radioactive material granted by any license issued pursuant to this part shall be
transferred, assigned, or in any manner disposed of, either voluntarily or involuntarily,
directly or indirectly, through transfer of control of any license to any person unless the
Department shall, after securing full information, find that the transfer is in accordance
with the provisions of the Act, now or hereafter in effect, and to all valid rules, regulations,
and orders of the Department, and shall give its consent in writing.
3.15.2.2
An application for transfer of license must include:
(1)
The identity, technical and financial qualifications of the proposed transferee;
(2)
Financial assurance for decommissioning information required by 3.9.6;
(3)
A description of the acquisition or proposed transfer including dates;
(4)
An updated organizational chart including the proposed transferee’s
management structure for the licensed activities;
(5)
Documentation of registration with the Colorado Secretary of State for the
proposed transferee;
(6)
A statement from the proposed transferee's management that they will conduct
business in accord with all of the commitments previously submitted by the
current licensee;
(7)
A statement from the proposed transferee's management accepting liability for all
licensed materials that are and have been possessed under the license; and
(8)
A copy of the appropriate radioactive materials license application signed by the
RSO and the proposed transferee's management.
3.15.3 Each person licensed by the Department pursuant to this part shall confine use and possession
of the material licensed to the locations and purposes authorized in the license. Except as
otherwise provided in the license, a license issued pursuant to Part 3 shall carry with it the right to
receive, possess, and use source or byproduct material. Preparation for shipment and transport
of source or radioactive material shall be in accordance with the provisions of Part 17.
3.15.4 Notice and Disposition of Records Prior to License Termination.
3.15.4.1
Each licensee shall notify the Department in writing when the licensee decides to
permanently discontinue all activities involving materials authorized under the license.
3.15.4.2
Prior to license termination, each licensee authorized to possess radioactive
material with a half-life greater than 120 days, in an unsealed form, shall forward the
following records to the Department.
(1)
Records of disposal required by 4.48; and
(2)
Records of surveys required by 4.42.
3.15.4.3
If licensed activities are transferred or assigned in accordance with 3.15.2, each
licensee authorized to possess radioactive material, with a half-life greater than 120 days,
in an unsealed form, shall transfer the records required in 3.15.4.2 to the new licensee
and the new licensee will be responsible for maintaining these records until the license is
terminated.
3.15.4.4
Prior to license termination, each licensee shall forward the records required by
3.16.5 to the Department.
3.15.5 Bankruptcy.
3.15.5.1
Each specific licensee and each general license that is required to register by
3.6.4.3 of this part shall notify the Department in writing immediately following the filing of
a voluntary or involuntary petition for bankruptcy under any Chapter of Title 11
(Bankruptcy) of the United States Code by or against:
(1)
The licensee;
(2)
An entity (as that term is defined in 11 U.S.C. 101(15)) controlling the licensee or
listing the license or licensee as property of the estate; or
(3)
An affiliate (as that term is defined in 11 U.S.C. 101(2)) of the licensee.
3.15.5.2
The notification specified in 3.15.5.1 shall include the bankruptcy court in which
the petition for bankruptcy was filed and the date of the filing of the petition.
3.15.6 Each licensee preparing technetium-99m radiopharmaceuticals from molybdenum-99/technetium-
99m generators or rubidium-82 from strontium-82/rubidium-82 generators shall test the generator
eluates for molybdenum-99 breakthrough or strontium-82 and strontium-85 contamination,
respectively, in accordance with Part 7. The licensee shall record the results of each test and
retain each record for 3 years after the record is made. The licensee shall report the results of
any test that exceeds the permissible concentration listed in Part 7, Section 7.33.1 at the time of
generator elution, in accordance with Part 7, Section 7.33.5.
3.15.7 Authorization under 3.8.10 to produce Positron Emission Tomography (PET) radioactive drugs for
noncommercial transfer to medical use licensees in its consortium does not relieve the licensee
from complying with applicable FDA, other Federal, and State requirements governing radioactive
drugs.
3.15.7.1
Each licensee authorized under 3.8.10 to produce PET radioactive drugs for
noncommercial transfer to medical use licensees in its consortium shall:
(1)
Satisfy the labeling requirements in 3.12.10.1(4) for each PET radioactive drug
transport radiation shield and each syringe, vial, or other container used to hold a
PET radioactive drug intended for noncommercial distribution to members of its
consortium.
(2)
Possess and use instrumentation to measure the radioactivity of the PET
radioactive drugs intended for noncommercial distribution to members of its
consortium and meet the procedural, radioactivity measurement, instrument test,
instrument check, and instrument adjustment requirements in 3.12.10.3.
3.15.7.2
A licensee that is a pharmacy authorized under 3.8.10 to produce PET
radioactive drugs for noncommercial transfer to medical use licensees in its consortium
shall require that any individual that prepares PET radioactive drugs shall be:
(1)
An authorized nuclear pharmacist that meets the requirements in 3.12.10.2(2),
or
(2)
An individual under the supervision of an authorized nuclear pharmacist as
specified in Part 7, Section 7.10.
3.15.7.3
A pharmacy, authorized under 3.8.10 to produce PET radioactive drugs for
noncommercial transfer to medical use licensees in its consortium that allows an
individual to work as an authorized nuclear pharmacist, shall meet the requirements of
3.12.10.2(5).
3.16
Expiration, Decommissioning and Termination of Licenses.
3.16.1 Definition of “principal activity”.
3.16.1.1
As used in this regulation, “principal activity” means an activity authorized by the
license which is essential to achieving the purpose(s) for which the license was issued or
amended.
3.16.1.2
Not included as principal activities are:
(1)
Radioactive material storage while no licensed material is accessed for use or
disposal; and
(2)
Any activity incidental to decontamination or decommissioning.
3.16.2 Expiration.
3.16.2.1
Except as provided in 3.17.2, each specific license shall expire at the end of the
specified day in the month and year stated therein.
3.16.2.2
Each specific license revoked by the Department expires at the end of the day on
the date of final determination to revoke the license, or on the expiration date stated in
the determination, or as otherwise provided by order.
3.16.2.3
With respect to possession of radioactive material and residual radioactive
contamination, each specific license continues in effect beyond the expiration date until
the Department notifies the licensee in writing that the license is terminated, even if:
(1)
The licensee decides not to renew the license;
(2)
No application for license renewal is submitted;
(3)
An application for renewal is denied; or
(4)
The Department modifies or suspends a license.
3.16.2.4
No less than 30 days before the expiration date specified in the license, the
licensee shall either:
(1)
Submit an application for license renewal under 3.17; or
(2)
Notify the Department, in writing, that the licensee has decided not to renew the
license.
3.16.2.5
If a licensee does not submit an application for license renewal under 3.17, the
licensee shall, on or before the expiration date specified in the license:
(1)
Terminate use of radioactive material;
(2)
Transfer radioactive materials to an authorized recipient and/or properly dispose
of radioactive material;
(3)
Reduce residual radioactive contamination to levels which are as low as
reasonably achievable (ALARA); and
(4)
Submit a completed Department Form R-23, Request for Termination of a
Radioactive Materials License, or equivalent information requesting license
termination, including survey results, leak tests, disposal records, and/or other
documentation which demonstrates acceptable conditions for license termination
as specified in 3.16.6.
3.16.2.6
Each licensee who possesses radioactive material, including residual radioactive
contamination attributable to licensed activities, following the expiration date specified in
the license shall:
(1)
Limit actions involving radioactive material to those related to decontamination
and other activities related to preparation for release for unrestricted use; and
(2)
Continue to control entry to restricted areas until they are suitable for release for
unrestricted use or the Department notifies the licensee in writing that the license
is terminated.
3.16.2.7
Each licensee or person responsible for a facility or site which includes a non-
exempt source of radiation or which may be contaminated by residual radioactivity shall,
no less than 30 days before vacating or relinquishing possession or control of the facility
or site, notify the Department, in writing, of the intent to vacate.
3.16.3 Timely Decommissioning.
3.16.3.1
Each licensee or person in possession of a non-exempt source of radiation who
decides to terminate all activities involving that source of radiation shall notify the
hazardous materials and waste management division immediately, in writing.
3.16.3.2
The licensee shall notify the Hazardous Materials And Waste Management
Division in writing within 60 days of the occurrence of any of the following:
(1)
The licensee has decided to permanently cease principal activities, as defined in
this part, at the entire site or in any separate building or outdoor area that
contains residual radioactivity such that the building or outdoor area is unsuitable
for unrestricted use in accordance with 4.61; or
(2)
No principal activities under the license have been conducted for a period of 24
months; or
(3)
No principal activities have been conducted for a period of 24 months in any
separate building or outdoor area that contains residual radioactivity such that
the building or outdoor area is unsuitable for unrestricted use in accordance with
these regulations.
3.16.3.3
Concurrent with the notification of the Hazardous Materials And Waste
Management Division required in 3.16.3.1 and 3.16.3.2, the licensee shall either:
(1)
Begin decommissioning activities; or,
(2)
Within 12 months of notification, submit a decommissioning plan if required by
3.16.4, and begin decommissioning upon approval of that plan.
3.16.3.4
Licensees shall complete decommissioning of the site or separate building or
outdoor area as soon as practicable but no later than 24 months following the initiation of
decommissioning, unless an alternate schedule addressing the factors in 3.16.4 is
requested and approved by the Department.
3.16.3.5
When decommissioning involves the entire site, the licensee shall request
license termination upon completion of decommissioning activities.
3.16.3.6
The Department may approve alternate schedules for the submission of plans
and for the completion of decommissioning as required pursuant to 3.16.3.3 and 3.16.3.4
if the Department determines that the alternate schedule:
(1)
Is necessary to effectively conduct decommissioning;
(2)
Presents no undue risks to public health and safety; and
(3)
Is otherwise in the public interest.
3.16.4 Decommissioning Plan.
3.16.4.1
A licensee must submit a decommissioning plan:
(1)
If the licensee intends to terminate the license using radiological criteria specified
in 4.61.3 or 4.61.4 (the exemption of 4.61.1.1 applies);
(2)
If required otherwise by these regulations;
(3)
If required by license condition; or
(4)
If the procedures and activities necessary to carry out decommissioning of the
site or separate building or outdoor area have not been previously approved by
the Department and these procedures could increase potential health and safety
impacts to workers or to the public, such as in any of the following cases:
(a)
Procedures would involve techniques not applied routinely during
cleanup or maintenance operations;
(b)
Workers would be entering areas not normally occupied where surface
contamination and radiation levels are significantly higher than routinely
encountered during operation;
(c)
Procedures could result in significantly greater airborne concentrations of
radioactive materials than are present during operation; or
(d)
Procedures could result in significantly greater releases of radioactive
material to the environment than those associated with operation.
3.16.4.2
Procedures such as those listed in 3.16.4.1 of this section with potential health
and safety impacts may not be carried out prior to Department approval of the
decommissioning plan.
3.16.4.3
The decommissioning plan for the site or separate building or outdoor area must
include:
(1)
A description of the conditions of the site, separate buildings, and/or outdoor
areas sufficient to evaluate the acceptability of the plan;
(2)
A description of planned decommissioning activities and a schedule for
completion;
(3)
A description of methods used to ensure protection of workers and the
environment against radiation hazards during decommissioning;
(4)
A description of the planned final radiation survey;
(5)
A current detailed cost estimate for decommissioning, comparison of that
estimate with present funds set aside for decommissioning, and a plan for
assuring the availability of adequate funds for completion of decommissioning;
and
(6)
A description of the intended final condition of the site, separate buildings, and/or
outdoor areas upon completion of decommissioning activities.
(7)
Decommissioning plans proposing the use of radiological criteria specified in
4.61.3 or 4.61.4, must also include:
(a)
An analysis demonstrating that reductions in residual radioactivity
necessary to comply with the provisions of 4.61.2 would result in net
public or environmental harm or were not being made because the
residual levels of contamination associated with restricted conditions are
ALARA.
(i)
Determination of dose and residual radioactivity levels which are
ALARA must take into
This text is long and has been trimmed here. Open the source document for the complete record.
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.